grepcent / static financial knowledge base

LUXFER HOLDINGS PLC (LXFR)

CIK: 0001096056. SIC: 2810 Industrial Inorganic Chemicals. Latest 10-K as of: 2026-02-24.

SIC breadcrumb: Manufacturing > Chemicals And Allied Products > SIC 2810 Industrial Inorganic Chemicals

SEC company page: https://www.sec.gov/edgar/browse/?CIK=1096056. Latest filing source: 0001096056-26-000015.

Informational only - descriptive public-record data, not investment advice.

Business

Read LXFR's verbatim Item 1 Business section from its latest 10-K: Business.

Risk Factors

Read LXFR's verbatim Item 1A Risk Factors from its latest 10-K: Risk Factors.

Selected Fundamentals

MetricValueUnitFYFiled
Revenue384,600,000USD20252026-02-24
Net income7,700,000USD20252026-02-24
Assets369,700,000USD20252026-02-24

Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-24. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001096056.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

Download these verified figures (annual + quarterly, with per-value filing provenance): JSON · CSV

Flow metrics use full-year FY periods from 10-K/10-K/A filings; balance-sheet metrics use FY-end instants. Free cash flow = operating cash flow - capital expenditures. Missing metrics are omitted rather than fabricated.

Metric2016201720182019202020212022202320242025
Revenue414,800,000441,300,000401,900,000373,400,000324,800,000374,100,000423,400,000405,000,000391,900,000384,600,000
Net income17,800,00016,600,00025,000,0003,100,00020,000,00029,900,00026,900,000-1,900,00018,400,0007,700,000
Operating income32,900,00021,900,00033,600,00018,700,00028,500,00036,200,00044,800,0004,200,00030,100,00024,000,000
Gross profit94,600,000108,600,000117,900,000103,700,00080,900,00096,000,00095,000,00076,600,00085,700,00089,200,000
Diluted EPS0.670.620.900.110.721.070.98-0.070.680.28
Operating cash flow20,600,00038,800,00063,200,0005,800,00049,600,00026,100,00015,900,00026,300,00051,100,00034,000,000
Capital expenditures16,600,00010,500,00013,200,00013,100,0008,000,0009,100,0008,300,0009,400,00010,300,0007,800,000
Dividends paid13,300,00013,300,00013,400,00013,600,00013,600,00013,600,00014,200,00014,000,00014,000,00013,900,000
Share buybacks7,300,0000.000.000.000.006,400,00011,100,0002,700,0002,300,0003,100,000
Assets399,800,000415,800,000408,800,000390,300,000346,400,000368,800,000407,100,000372,100,000382,400,000369,700,000
Liabilities241,300,000224,500,000215,900,000179,300,000159,700,000199,800,000159,500,000162,900,000143,300,000
Stockholders' equity150,400,000174,500,000184,300,000174,400,000167,100,000209,100,000207,300,000212,600,000219,500,000226,400,000
Cash and cash equivalents12,600,00013,800,00010,200,0001,500,0006,200,00012,600,0002,300,0004,100,0008,300,000
Free cash flow4,000,00028,300,00050,000,000-7,300,00041,600,00017,000,0007,600,00016,900,00040,800,00026,200,000

Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

Metric2016201720182019202020212022202320242025
Net margin4.29%3.76%6.22%0.83%6.16%7.99%6.35%-0.47%4.70%2.00%
Operating margin7.93%4.96%8.36%5.01%8.77%9.68%10.58%1.04%7.68%6.24%
Return on equity11.84%9.51%13.56%1.78%11.97%14.30%12.98%-0.89%8.38%3.40%
Return on assets4.45%3.99%6.12%0.79%5.77%8.11%6.61%-0.51%4.81%2.08%
Liabilities / equity1.381.221.241.070.760.960.750.740.63
Current ratio2.031.992.432.311.951.822.601.881.67

Industry Peer Context

Each number-line places LXFR against the min, median, and max of latest reported values among companies in the same SIC industry when at least three peers report that ratio.

Net margin peer context

LXFR Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 9.LXFR Net margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 9.9 SIC peersMin -23.9%Median -2.8%Max 20.3%LXFR 2.0%

Operating margin peer context

LXFR Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 9.LXFR Operating margin versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 9.9 SIC peersMin -8.7%Median 3.0%Max 26.3%LXFR 6.2%

ROE peer context

LXFR ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 10.LXFR ROE versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 10.10 SIC peersMin -33.1%Median -4.1%Max 18.0%LXFR 3.4%

ROA peer context

LXFR ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 10.LXFR ROA versus SIC peer range. Source: grepcent computed from latest SEC companyfacts ratios for SIC industry 2810; peer count 10.10 SIC peersMin -9.6%Median -1.6%Max 7.9%LXFR 2.1%

Financial Bridges

Waterfall figures reconcile reported SEC companyfacts components. Missing bridges are omitted when required components are not present for the same fiscal year.

Income statement bridge from reported figures

LXFR FY2025 income statement bridge from reported figures.LXFR FY2025 income statement bridge from reported figures.LXFR income bridgeFY2025: revenue to net incomeSource: SEC companyfacts FY2025.Income statement bridgeReported amount$0.0B$250.0M$500.0M$384.6MRevenue-$295.4MCost$89.2MGross-$65.2MOpEx$24.0MOperating-$16.3MOther/tax$7.7MNet income

Figure provenance: SEC companyfacts FY 2025. Revenue: accession 0001096056-26-000015; concept RevenueFromContractWithCustomerExcludingAssessedTax; source concepts us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Gross profit: accession 0001096056-26-000015; concept GrossProfit; source concepts us-gaap:GrossProfit | Operating income: accession 0001096056-26-000015; concept OperatingIncomeLoss; source concepts us-gaap:OperatingIncomeLoss | Net income: accession 0001096056-26-000015; concept NetIncomeLoss; source concepts us-gaap:NetIncomeLoss

Free cash flow = operating cash flow - capital expenditures

LXFR FY2025 free cash flow bridge from reported figures.LXFR FY2025 free cash flow bridge from reported figures.LXFR free cash flow bridgeFY2025: operating cash flow less capital expendituresSource: SEC companyfacts FY2025.Free cash flow bridgeReported amount$0.0B$125.0M$250.0M$34.0MOperating cash flow-$7.8MCapex$26.2MFree cash flow

Figure provenance: SEC companyfacts FY 2025. Operating cash flow: accession 0001096056-26-000015; concept NetCashProvidedByUsedInOperatingActivities; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities | Capital expenditures: accession 0001096056-26-000015; concept PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Free cash flow: accession 0001096056-26-000015; concept NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment; source concepts us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

Financial Charts

LXFR revenue, last 5 periods. Source: SEC companyfacts FY2025.LXFR revenue, last 5 periods. Source: SEC companyfacts FY2025.LXFR RevenueLatest point: FY2025 = $384.6MSource: SEC companyfacts FY2025.Fiscal yearReported revenue$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

LXFR net income, last 5 periods. Source: SEC companyfacts FY2025.LXFR net income, last 5 periods. Source: SEC companyfacts FY2025.LXFR Net incomeLatest point: FY2025 = $7.7MSource: SEC companyfacts FY2025.Fiscal yearNet income-$250.0M$0.0B$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

LXFR operating income, last 5 periods. Source: SEC companyfacts FY2025.LXFR operating income, last 5 periods. Source: SEC companyfacts FY2025.LXFR Operating incomeLatest point: FY2025 = $24.0MSource: SEC companyfacts FY2025.Fiscal yearOperating income$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: OperatingIncomeLoss. Source concepts: us-gaap:OperatingIncomeLoss.

LXFR gross profit, last 5 periods. Source: SEC companyfacts FY2025.LXFR gross profit, last 5 periods. Source: SEC companyfacts FY2025.LXFR Gross profitLatest point: FY2025 = $89.2MSource: SEC companyfacts FY2025.Fiscal yearGross profit$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: GrossProfit. Source concepts: us-gaap:GrossProfit.

LXFR diluted eps, last 5 periods. Source: SEC companyfacts FY2025.LXFR diluted eps, last 5 periods. Source: SEC companyfacts FY2025.LXFR Diluted EPSLatest point: FY2025 = $0.28/shareSource: SEC companyfacts FY2025.Fiscal yearDiluted EPS (USD/share)-$0.50/share$0.00/share$1.50/shareFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

LXFR operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.LXFR operating cash flow, last 5 periods. Source: SEC companyfacts FY2025.LXFR Operating cash flowLatest point: FY2025 = $34.0MSource: SEC companyfacts FY2025.Fiscal yearOperating cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities.

LXFR capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.LXFR capital expenditures, last 5 periods. Source: SEC companyfacts FY2025.LXFR Capital expendituresLatest point: FY2025 = $7.8MSource: SEC companyfacts FY2025.Fiscal yearCapital expenditures$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

LXFR dividends paid, last 5 periods. Source: SEC companyfacts FY2025.LXFR dividends paid, last 5 periods. Source: SEC companyfacts FY2025.LXFR Dividends paidLatest point: FY2025 = $13.9MSource: SEC companyfacts FY2025.Fiscal yearDividends paid$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: PaymentsOfDividends. Source concepts: us-gaap:PaymentsOfDividends.

LXFR share buybacks, last 5 periods. Source: SEC companyfacts FY2025.LXFR share buybacks, last 5 periods. Source: SEC companyfacts FY2025.LXFR Share buybacksLatest point: FY2025 = $3.1MSource: SEC companyfacts FY2025.Fiscal yearShare buybacks$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: PaymentsForRepurchaseOfCommonStock. Source concepts: us-gaap:PaymentsForRepurchaseOfCommonStock.

LXFR assets, last 5 periods. Source: SEC companyfacts FY2025.LXFR assets, last 5 periods. Source: SEC companyfacts FY2025.LXFR AssetsLatest point: FY2025 = $369.7MSource: SEC companyfacts FY2025.Fiscal yearAssets$0.0B$250.0M$500.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: Assets. Source concepts: us-gaap:Assets.

LXFR liabilities, last 5 periods. Source: SEC companyfacts FY2025.LXFR liabilities, last 5 periods. Source: SEC companyfacts FY2025.LXFR LiabilitiesLatest point: FY2025 = $143.3MSource: SEC companyfacts FY2025.Fiscal yearLiabilities$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: Liabilities. Source concepts: us-gaap:Liabilities.

LXFR stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.LXFR stockholders' equity, last 5 periods. Source: SEC companyfacts FY2025.LXFR Stockholders' equityLatest point: FY2025 = $226.4MSource: SEC companyfacts FY2025.Fiscal yearStockholders' equity$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: StockholdersEquity. Source concepts: us-gaap:StockholdersEquity.

LXFR cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.LXFR cash and cash equivalents, last 5 periods. Source: SEC companyfacts FY2025.LXFR Cash and cash equivalentsLatest point: FY2025 = $8.3MSource: SEC companyfacts FY2025.Fiscal yearCash and cash equivalents$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: CashAndCashEquivalentsAtCarryingValue. Source concepts: us-gaap:CashAndCashEquivalentsAtCarryingValue.

LXFR free cash flow, last 5 periods. Source: SEC companyfacts FY2025.LXFR free cash flow, last 5 periods. Source: SEC companyfacts FY2025.LXFR Free cash flowLatest point: FY2025 = $26.2MSource: SEC companyfacts FY2025.Fiscal yearFree cash flow$0.0B$125.0M$250.0MFY2021FY2022FY2023FY2024FY2025

Figure provenance: SEC companyfacts. Latest point: FY 2025 ended 2025-12-31; accession 0001096056-26-000015; filed 2026-02-24. Concept: NetCashProvidedByUsedInOperatingActivities - PaymentsToAcquirePropertyPlantAndEquipment. Source concepts: us-gaap:NetCashProvidedByUsedInOperatingActivities; us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-04-28. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001096056.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

QuarterEnd DateRevenueNet IncomeDiluted EPSMethod
2022-Q22022-06-260.34reported discrete quarter
2022-Q32022-09-250.29reported discrete quarter
2023-Q12023-04-020.02reported discrete quarter
2023-Q22023-04-02500,000reported discrete quarter
2023-Q22023-07-02110,400,0000.17reported discrete quarter
2023-Q32023-07-024,700,000reported discrete quarter
2023-Q32023-10-0197,400,000-0.05reported discrete quarter
2023-Q42023-12-3195,900,000-5,800,000derived Q4 = FY annual - nine-month YTD
2024-Q12024-03-3189,400,0002,700,0000.10reported discrete quarter
2024-Q22024-03-312,700,000reported discrete quarter
2024-Q22024-06-3099,700,000-0.02reported discrete quarter
2024-Q32024-06-30-500,000reported discrete quarter
2024-Q32024-09-2999,400,0000.47reported discrete quarter
2024-Q42024-12-31103,400,0003,500,000derived Q4 = FY annual - nine-month YTD
2025-Q12025-03-3097,000,0005,500,0000.20reported discrete quarter
2025-Q22025-03-305,500,000reported discrete quarter
2025-Q22025-06-29104,000,0000.10reported discrete quarter
2025-Q32025-06-292,600,000reported discrete quarter
2025-Q32025-09-2892,900,0000.10reported discrete quarter
2025-Q42025-12-3190,700,000-3,100,000derived Q4 = FY annual - nine-month YTD
2026-Q12026-03-2983,900,0003,600,0000.13reported discrete quarter

Quarterly Charts

LXFR quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q1.LXFR quarterly revenue, last 12 periods. Source: SEC companyfacts 2026-Q1.LXFR Quarterly RevenueLatest point: 2026-Q1 = $83.9MSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Revenue$0.0B$125.0M$250.0M2023-Q22023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-29; accession 0001437749-26-013676; filed 2026-04-28. Concept: RevenueFromContractWithCustomerExcludingAssessedTax. Source concepts: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

LXFR quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q1.LXFR quarterly net income, last 12 periods. Source: SEC companyfacts 2026-Q1.LXFR Quarterly Net incomeLatest point: 2026-Q1 = $3.6MSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Net income-$250.0M$0.0B$250.0M2023-Q22023-Q32023-Q42024-Q12024-Q22024-Q32024-Q42025-Q12025-Q22025-Q32025-Q42026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-29; accession 0001437749-26-013676; filed 2026-04-28. Concept: NetIncomeLoss. Source concepts: us-gaap:NetIncomeLoss.

LXFR quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q1.LXFR quarterly diluted eps, last 12 periods. Source: SEC companyfacts 2026-Q1.LXFR Quarterly Diluted EPSLatest point: 2026-Q1 = $0.13/shareSource: SEC companyfacts 2026-Q1.Fiscal quarterQuarterly Diluted EPS (USD/share)-$0.50/share$0.00/share$1.00/share2022-Q22022-Q32023-Q12023-Q22023-Q32024-Q12024-Q22024-Q32025-Q12025-Q22025-Q32026-Q1

Figure provenance: SEC companyfacts. Latest point: FY 2026 ended 2026-03-29; accession 0001437749-26-013676; filed 2026-04-28. Concept: EarningsPerShareDiluted. Source concepts: us-gaap:EarningsPerShareDiluted.

Macro Cross-References

Latest quarter (10-Q)

Latest 10-Q source: 0001437749-26-024682.

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Confidence: high. Filing date: 2026-07-28. Report date: 2026-06-28.

Item 2.           Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Interim Report on Form 10-Q contains certain statements, statistics and projections that are, or may be, forward-looking, including with respect to the Transaction. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Interim Report, as well as:

uncertainties as to the timing of the proposed Transaction;
the risk that competing offers or acquisition proposals will be made;
the possibility that various conditions to the consummation of the proposed Transaction contained in the Transaction Agreement may not be satisfied or waived (including, but not limited to, the failure to obtain the Company Shareholder Approval and the failure to obtain the sanction of the Court);
the occurrence of any event, change or other circumstances that could give rise to the termination of the Transaction Agreement;
the effects of disruption from the transactions contemplated by the Transaction Agreement and the impact of the announcement and pendency of the Transaction on the Company’s business, including its ability to retain and hire key personnel and maintain relationships with customers;
the risk that any announcements relating to the Transaction could have adverse effects on the market price of the Company’s ordinary shares;
the risk of any unexpected costs or expenses resulting from the Transaction;
the risk that shareholder litigation in connection with the Transaction may result in significant costs of defense, indemnification and liability;
general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;
worldwide economic and business conditions and conditions in the industries in which we operate;
potential or actual tariffs, and other political risks worldwide;
future pandemics;
fluctuations in the cost and / or availability of raw materials, including Chinese rare earths, labor and energy, as well as our ability to pass on cost increases to customers;
currency fluctuations and other financial risks;
our ability to protect our intellectual property;
the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;
relationships with our customers and suppliers;
increased competition from other companies in the industries in which we operate;
changing technology;
our ability to execute and integrate new acquisitions;
claims for personal injury, death or property damage arising from the use of products produced by us;
the occurrence of accidents or other interruptions to our production processes;
changes in our business strategy or development plans, and our expected level of capital expenditure;
our ability to attract and retain qualified personnel;

23

Table of Contents

restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;
climate change regulations and the potential impact on energy costs;
regulatory, environmental, legislative and judicial developments; and
our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," on Form 10-K and "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Risk factors" of this Interim Report on Form 10-Q for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and specialty industrial applications.

Recent Developments

On July 26, 2026, the Company entered into the Transaction Agreement with Buyer. Pursuant to the Transaction Agreement, upon the terms and subject to the conditions set forth therein, Buyer will acquire the entire issued share capital of the Company pursuant to the Scheme of Arrangement. Upon the terms and subject to the conditions set forth in the Transaction Agreement and the Scheme of Arrangement, at the Effective Time, all of the ordinary shares of the Company then outstanding will be transferred from the Company’s shareholders to Buyer, and the Company’s shareholders will be entitled, pursuant to and in accordance with the terms of the Scheme of Arrangement, to receive $17.37 in cash per ordinary share. The Company Board approved and declared the Transaction Agreement, and the transactions contemplated thereby, including the Transaction, the Scheme of Arrangement and the other transactions contemplated thereby fair to and in the best interests of the Company and its shareholders as a whole. See Note 16 of the Notes to Condensed Consolidated Financial Statements for additional information.

Key trends regarding our existing business

Operating objectives and trends

In 2026, we expect the following operating objectives and trends to impact our business:

Execution of the proposed Transaction;
Focus on navigating near-term uncertainties while maintaining strategic discipline for long-term growth;
Column 1Column 2Column 3
Completion of the centers of excellence programs involving footprint optimization, manufacturing excellence through automation and margin improvement;
Column 1Column 2Column 3
Navigating market volatility, tariffs and wider impact from these, including alternative sourcing arrangements for rare earth materials;
Column 1Column 2Column 3
Execution of select capital investment projects to support our strategy of profitable growth while improving our infrastructure;
Column 1Column 2Column 3
Continued emphasis on operating cash generation and maintaining strong working capital performance; and
Column 1Column 2Column 3
Focus on recruiting, developing, maintaining talent, and driving a high-performance culture.

24

Table of Contents

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations for Luxfer in the Second Quarter of 2026 and 2025 were as follows:

Second Quarter% / point change
In millions202620252026 v 2025
Net sales$95.7$106.6(10.2)%
Cost of goods sold(71.2)(81.9)(13.1)%
Gross profit24.524.7(0.8)%
% of net sales25.6%23.2%2.4
Selling, general and administrative expenses(12.3)(13.5)(8.9)%
% of net sales12.9%12.7%0.2
Research and development(1.6)(1.1)45.5%
% of net sales1.7%1.0%0.7
Restructuring charges(1.6)(2.0)(20.0)%
% of net sales1.7%1.9%(0.2)
Disposal related costs(0.1)(100.0)%
% of net sales%0.1%(0.1)
Loss on disposal of assets held-for-sale(2.8)(100.0)%
% of net sales%2.6%(2.6)
Other costs(1.2)n/a
% of net sales1.3%%1.3
Operating income7.85.250.0%
% of net sales8.2%4.9%3.3
Net interest expense(1.0)(0.9)11.1%
% of net sales1.0%0.8%0.2
Defined benefit pension (charge) / credit(0.1)0.6(116.7)%
% of net sales0.1%0.6%(0.5)
Income before income taxes6.74.936.7%
% of net sales7.0%4.6%2.4
Provision for income taxes(1.9)(2.3)(17.4)%
Effective tax rate28.4%46.9%(18.5)
Net income from continuing activities$4.8$2.684.6%
% of net sales5.0%2.4%2.6

25

Table of Contents

The consolidated results of operations for Luxfer in the first six months of 2026 and 2025 were as follows:

[[GREPCENT_TABLE]]
[["","","Year-to-date","","","% / point change"],["In millions","","2026","","","2025","","","2026 v 2025"],["Net sales","","$","181.4","","","$","205.1","","","","(11.6",")%"],["Cost of goods sold","","","(134.4",")","","","(158.9",")","","","(15.4",")%"],["Gross profit","","$","47.0","","","$","46.2","","","","1.7","%"],["% of net sales","","","25.9","%","","","22.5","%","","","3.4"],["Selling, general and administrative expenses","","","(24.7",")","","","(26.5",")","","","(6.8",")%"],["% of net sales","","","13.6","%","","","12.9","%","","",

[Excerpt truncated for page length; source filing is linked above.]

Latest 10-K MD&A

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2026-02-24. Report date: 2025-12-31.

Item 7.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Annual Report on Form 10-K contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Annual Report, as well as:

•general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

•worldwide economic and business conditions and conditions in the industries in which we operate;

•potential or actual tariffs, and other political risks worldwide;

•future pandemics;

•fluctuations in the cost and / or availability of raw materials, including Chinese rare earths, labor and energy, as well as our ability to pass on cost increases to customers;

•currency fluctuations and other financial risks;

•our ability to protect our intellectual property;

•the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

•relationships with our customers and suppliers;

•increased competition from other companies in the industries in which we operate;

•changing technology;

•our ability to execute and integrate new acquisitions;

•claims for personal injury, death or property damage arising from the use of products produced by us;

•the occurrence of accidents or other interruptions to our production processes;

•changes in our business strategy or development plans, and our expected level of capital expenditure;

•our ability to attract and retain qualified personnel;

•restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

•climate change regulations and the potential impact on energy costs;

•regulatory, environmental, legislative and judicial developments; and

•our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," of this Annual Report on Form 10-K for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

23

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and specialty industrial applications.

Key trends regarding our existing business

Operating objectives and trends

In 2026, we expect the following operating objectives and trends to impact our business:

•Focus on navigating near-term uncertainties while maintaining strategic discipline for long-term growth;

•Completion of recently launched centers of excellence programs involving footprint optimization, manufacturing excellence through automation and margin improvement;

•Navigating market volatility, tariffs and wider impact from these, including alternative sourcing arrangements for rare earth materials;

•Execution of select capital investment projects to support our strategy of profitable growth while improving our infrastructure;

•Continued emphasis on operating cash generation and maintaining strong working capital performance; and

•Focus on recruiting, developing, maintaining talent, and driving a high-performance culture.

•Continued evaluation of strategic alternatives in response to the strategic review concluded in 2024.

24

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations from continuing operations of Luxfer were as follows:

Years ended December 31,% / point change
In millions2025202420232025 v 20242024 v 2023
Net sales$384.6$391.9$405.0(1.9)%(3.2)%
Cost of sales(295.4)(306.2)(328.4)(3.5)%(6.8)%
Gross profit89.285.776.64.1%11.9%
% of net sales23.2%21.9%18.9%1.33.0
Selling, general and administrative expenses(49.1)(48.1)(48.7)2.1%(1.2)%
% of net sales12.8%12.3%12.0%0.50.3
Research and development(4.3)(4.4)(4.6)(2.3)%(4.3)%
% of net sales1.1%1.1%1.1%
Restructuring charges(9.0)(4.7)(6.4)91.5%(26.6)%
% of net sales2.3%1.2%1.6%1.1(0.4)
Impairment charges(12.7)(100.0)%
% of net sales%%3.1%(3.1)
Disposal related costs(2.0)(12.2)(83.6)%n/a
% of net sales0.5%3.1%%(2.6)3.1
Other (costs) / income(0.8)7.7(110.4)%n/a
% of net sales(0.2)%2.0%%(2.2)2.0
Gain on disposal of assets held-for-sale6.1(100.0)%n/a
% of net sales%1.6%%(1.6)1.6
Operating income24.030.14.2(20.3)%616.7%
% of net sales6.2%7.7%1.0%(1.5)6.7
Net interest expense(3.1)(5.2)(6.3)(40.4)%(17.5)%
% of net sales0.8%1.3%1.6%(0.5)(0.3)
Defined benefit pension credit / (charge)1.31.6(7.6)(18.8)%(121.1)%
% of net sales0.3%0.4%(1.9)%(0.1)2.3
Income / (loss) before income taxes22.226.5(9.7)(16.2)%(373.2)%
% of net sales5.8%6.8%(2.4)%(1.0)9.2
(Provision) / credit for income taxes(9.1)(8.2)7.111.0%(215.5)%
Effective tax rate41.0%30.9%73.2%10.1(42.3)
Net income / (loss) from continuing operations$13.1$18.3$(2.6)(28.4)%(803.8)%
% of net sales3.4%4.7%(0.6)%(1.3)5.3

25

Net sales

Adjusting for foreign exchange tailwinds of $3.0 million (2024: tailwind of $1.7 million), and excluding Graphic Arts sales of $13.4 million (2024: $29.6 million) consolidated net sales have increased by $5.9 million or 1.6% in 2025 from 2024. Lower volumes and unfavorable mix reduced sales by $0.5 million, more than offset by $6.4 million from the pass-through of price increases.

Excluding Graphic Arts, sales in our Specialty Industrial and Defense, First Response and Healthcare end market have increased by 11.9% and 2.9% respectively, whilst our sales in our Transportation end market have decreased by 4.8%.

Revenue was positively impacted from:

•Strong sales of Meals Ready to Eat (MREs) and Unitized Group Rations (UGR-E);

•Greater demand for magnesium aerospace alloys;

•Increased sales of magnesium powders for both commercial and defense use; and

•Higher demand for cylinders used in aerospace and space exploration projects.

These increases have been partially offset by:

•Significant reduction in Alternative Fuel cylinder sales, as well as those used for SCBA and medical purposes; and

•Decrease in sales of zirconium powders, specifically those used for automotive catalysis.

Gross profit

Excluding Graphic Arts there was a 0.8 percentage point increase in gross profit as a percentage of sales in 2025 from 2024. This increase was primarily the result of positive sales mix, pricing discipline and continued operational execution across end markets, partially offset by the impact of higher fixed costs in the Elektron division linked to increased volumes and infrastructure investment.

Selling, general and administrative expenses ("SG&A")

Excluding Graphic Arts, SG&A costs as a percentage of sales have increased by 0.5 percentage points in 2025 from 2024.

Research and development costs

Excluding Graphic Arts, research and development costs as a percentage of sales remained flat in 2025 from 2024.

Restructuring charges

The $9.0 million restructuring charges in 2025 predominantly relates to costs aimed at reducing our fixed cost structure and generating savings through enhanced operational alignment, in particular to centralize our North American gas cylinders and magnesium powders businesses. We ceased manufacturing at our Pomona, California facility in December 2025.

As part of this initiative, we recognized impairment charges of $3.8 million related to property, plant and equipment in accordance with ASC 360, and $1.9 million related to right-of-use assets from operating leases in accordance with ASC 842, which applies the long-lived asset impairment model in ASC 360. The impairments were triggered by a strategic decision to relocate operations, resulting in the affected assets no longer being used for their originally intended period. Asset impairments of $0.8 million were recognized in relation to inventory to reflect inventory no longer recoverable as part of the relocation.

The remaining $2.5 million restructuring charge related to severance and other costs.

26

Disposal related costs

On July 2, 2025, the Company completed the divesture of its Graphic Arts business to Vulcan Metals Specialty Products, Inc., a newly created affiliate of TerraMar Capital LLC. Graphic Arts was previously reported as a separate operating segment under ASC 280.

The Company recognized a net loss on held-for-sale asset group of $1.9 million. Additional costs of $0.1 million represent professional fees incurred prior to the completion of the disposal of the Graphic Arts business.

In 2024 disposal related costs of $12.2 million were incurred in relation to the divestiture of our Graphic Arts segment. $9.8 million represents a loss on held-for-sale asset group to reflect its fair value at that time and $2.4 million represents professional fees.

Other (Costs) / income

Other Income of $7.7 million in 2024 relates to the recovery of legal costs from our insurer related to the previously disclosed US Ecology case, (see Note 20). Historically the legal costs relating to this case were in selling, general and administrative expenses.

In 2025, other costs of $0.8 million relate to fees incurred in relation the Company’s ongoing strategic review.

Gain on Disposal of assets held for sale

The $6.1 million gain on disposal recognized in 2024 was in relation to the sale of previously disclosed held-for-sale land and buildings in our Elektron division. Net consideration of $7.3 million was received in the fourth quarter of 2024.

Net interest expense

Net interest expense of $3.1 million in 2025 decreased from $5.2 million in 2024 primarily due to the lower average drawings on the revolving credit facility.

Defined benefit pension credit

The defined benefit pension credit of $1.3 million in 2025 relates to the U.K. plan and was broadly consistent with the $1.6 million credit recognized in 2024.

Provision for income taxes

The 10.1 percentage point increase in the effective tax rate in 2025 from 2024 was primarily due to difference of basis in accounting and state taxes.

2024 compared with 2023

For a discussion comparing our consolidated operating results for the year ended December 31, 2024, with the year ended December 31, 2023, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the U.S. Securities and Exchange Commission on February 25, 2025. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2025.

27

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following tables of non-GAAP summary financial data presents a reconciliation of net income from continuing operations and diluted earnings per ordinary share from continuing operations to adjusted net income from continuing operations, adjusted EBITA from continuing operations, adjusted income from continuing operations before income taxes, adjusted EBITDA from continuing operations, adjusted EBITDA excluding legal cost recovery, adjusted earnings per ordinary share from continuing operations, adjusted provision for income taxes and adjusted effective tax rate from continuing operations, for the periods presented, being the most comparable GAAP measures. Management believes that adjusted net income excluding legal cost recovery, adjusted earnings per share, adjusted EBITA and adjusted EBITDA excluding legal cost recovery are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income from continuing operations, adjusted earnings per share from continuing operations, adjusted EBITA from continuing operations and adjusted EBITDA excluding legal cost (recovery) from continuing operations in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability. In 2024, the Company initiated a process to divest the Graphic Arts business which was concluded in July 2025. While Graphic Arts did not meet the 'strategic shift' criteria outlined in ASC 205-20 for it to be classified as a discontinued operation, management believed it is appropriate in the tables below to separate out the results of Graphic Arts in order to provide a more complete financial summary for the period. Similarly for other income of $7.7 million in 2024 relates to the recovery of legal costs from our insurer related to the previously disclosed US Ecology case, historically the legal costs relating to this case were in selling, general and administrative expenses, however the other income in 2024 is separated due to its one-off nature and the recovery relating to several years. We believe separating the income and costs relating to this is also appropriate to provide a more complete financial summary for the period.

Year-to-date
In millions except per share data20252024
Continuing operationsGraphic ArtsAdjusted TotalContinuing operationsGraphic ArtsAdjusted Total
Net income / (loss)$13.1$(4.7)$17.8$18.3(13.9)$32.2
Accounting charges relating to acquisitions and disposals of businesses:
Amortization on acquired intangibles0.80.80.80.8
Disposal related costs2.02.012.212.2
Defined benefit pension credit(1.3)(1.3)(1.6)(1.6)
Restructuring charges9.09.04.74.7
Gain on disposal of assets held-for-sale(6.1)(6.1)
Other costs0.80.8
Share-based compensation charge3.60.23.43.50.53.0
Income tax on adjusted items0.40.7(0.3)(0.9)(0.6)(0.3)
Adjusted net income / (loss)28.4(1.8)30.230.9(1.8)32.7
Less:
Legal cost recovery(7.7)(7.7)
Tax on legal cost recovery1.81.8
Adjusted net income / (loss) excluding legal$28.4$(1.8)$30.2$25.0$(1.8)$26.8
Adjusted earnings / (loss) per ordinary share (1)
Diluted earnings / (loss) per ordinary share$0.48$(0.17)$0.65$0.68$(0.51)$1.19
Impact of adjusted items0.560.100.460.460.440.02
Adjusted diluted earnings / (loss) per ordinary share$1.04$(0.07)$1.11$1.14$(0.07)$1.21
Impact of legal cost recovery(0.22)(0.22)
Adjusted diluted earnings / (loss) per ordinary share excluding legal cost recovery$1.04$(0.07)$1.11$0.92$(0.07)$0.99

(1) For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees.

28

Year-to-date
In millions except per share data20252024
Continuing operationsGraphic ArtsAdjusted TotalContinuing operationsGraphic ArtsAdjusted Total
Adjusted net income / (loss)$28.4$(1.8)$30.2$30.9$(1.8)$32.7
Add back:
Income tax on adjusted items(0.4)(0.7)0.30.90.60.3
Income tax expense9.10.19.08.2(1.3)9.5
Net finance costs3.1(0.2)3.35.2(0.4)5.6
Adjusted EBITA40.2(2.6)42.845.2(2.9)48.1
Loss on disposal of property, plant and equipment0.10.1
Depreciation9.19.19.39.3
Adjusted EBITDA49.3(2.6)51.954.6(2.9)57.5
Less:
Legal cost recovery(7.7)(7.7)
Adjusted EBITDA excluding legal$49.3$(2.6)$51.9$46.9$(2.9)$49.8
Year-to-date
In millions except per share data20252024
Continuing operationsGraphic ArtsAdjusted TotalContinuing operationsGraphic ArtsAdjusted Total
Adjusted net income / (loss)$28.4$(1.8)$30.2$30.9$(1.8)$32.7
Add back:
Income tax on adjusted items(0.4)(0.7)0.30.90.60.3
Provision / (credit) for income taxes9.10.19.08.2(1.3)9.5
Adjusted income / (loss) before income taxes37.1(2.4)39.540.0(2.5)42.5
Adjusted provision / (credit) for income taxes8.7(0.6)9.39.1(0.7)9.8
Adjusted effective tax rate23.5%25.0%23.5%22.8%28.0%23.1%
2025
In millionsGas CylindersElektronGraphic ArtsTotal
Segment adjusted EBITA$11.7$31.1$(2.6)$40.2
Depreciation3.35.89.1
Segment adjusted EBITDA$15.0$36.9$(2.6)$49.3
2024
In millionsGas CylindersElektronGraphic ArtsTotal
Segment adjusted EBITA$14.6$33.5$(2.9)$45.2
Depreciation3.45.9$9.3
Loss on disposal of property, plant and equipment0.1$0.1
Segment adjusted EBITDA$18.0$39.5$(2.9)$54.6
2023
In millionsGas CylindersElektronGraphic ArtsTotal
Segment adjusted EBITA$12.6$20.8$(6.5)$26.9
Depreciation4.15.82.011.9
Segment adjusted EBITDA$16.7$26.6$(4.5)$38.8

29

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our three reportable segments during the year (Gas Cylinders, Elektron and Graphic Arts). The Graphic Arts business was sold on July 2, 2025. These segments comprise various product offerings that serve multiple end-markets.

Adjusted EBITA, which is our segment income metric, represents net income from continuing operations adjusted for share-based compensation charges, restructuring charges, impairment charges, disposal costs, loss / (gain) on disposal of assets held-for-sale, net interest expenses, defined benefits pension credit, provision for taxes and amortization. A reconciliation to pre-tax income can be found in ITEM 8, Note 18. Adjusted EBITDA, as shown below, represents adjusted EBITA less depreciation. Management believes that adjusted EBITA and adjusted EBITDA are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. Adjusted EBITDA is reconciled to adjusted EBITA above.

GAS CYLINDERS

The results of operations from the Gas Cylinders segment are for continuing operations only.

The net sales, adjusted EBITA and adjusted EBITDA for Gas Cylinders were as follows:

Years ended December 31,% / point change
In millions2025202420232025 v 20242024 v 2023
Net sales$174.8$186.3$186.4(6.2)%(0.1)%
Adjusted EBITA11.714.612.6(19.9)%15.9%
Adjusted EBITDA15.018.016.7(16.7)%7.8%
Adjusted EBITA % of net sales6.7%7.8%6.8%(1.1)1.0
Adjusted EBITDA % of net sales8.6%9.7%9.0%(1.1)0.7

Net sales

The 6.2% decrease in Gas Cylinders sales in 2025 from 2024 was primarily the result of:

•Continued softness in demand of Alternative Fuels cylinders;

•Lower sales of medical and SCBA cylinders.

These decreases have been partially offset by:

•Gains in sales of aerospace cylinders, which serve commercial aircraft and space exploration programs.

Adjusted EBITA

The 1.1 percentage point decrease in adjusted EBITA for Gas Cylinders as a percentage of net sales in 2025 from 2024 is the result of adverse sales mix partially offset by price and a foreign exchange tailwind.

Adjusted EBITDA

The 1.1 percentage point decrease in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2025 from 2024 is the result of the decrease in adjusted EBITA as a percentage of net sales.

30

ELEKTRON

The net sales, adjusted EBITA and adjusted EBITDA for Elektron were as follows:

Years ended December 31,% / point change
In millions2025202420232025 v 20242024 v 2023
Net sales$196.4$176.0$187.111.6%(5.9)%
Adjusted EBITA31.133.520.8(7.2)%61.1%
Adjusted EBITDA36.939.526.6(6.6)%48.5%
Adjusted EBITA % of net sales15.8%19.0%11.1%(3.2)7.9
Adjusted EBITDA % of net sales18.8%22.4%14.2%(3.6)8.2

Net sales

The 11.6% increase in Elektron sales in 2025 from 2024 was primarily the result of:

•Significant increase in sales of Meals Ready to Eat ("MREs") and Unitized Group Rations "(UGR-E");

•Increase in sales of magnesium powders for both commercial and defense use;

•Continued recovery in sales of magnesium aerospace alloys; and

•Improved demand for oil and gas alloys.

These increases were partially offset by:

•Decrease in sales of zirconium powders for both commercial and defense use; and

•Lower sales of automotive catalysis materials.

Adjusted EBITA

The 3.2 percentage point decrease in adjusted EBITA for Elektron as a percentage of net sales in 2025 from 2024 is the result of adverse price and a foreign exchange headwind.

Adjusted EBITDA

The 3.6 percentage point decrease in adjusted EBITDA for Elektron as a percentage of net sales in 2025 from 2024 was predominantly the result of the decrease in adjusted EBITA as a percentage of net sales.

GRAPHIC ARTS

The net sales, adjusted EBITA and adjusted EBITDA for Graphic Arts were as follows:

Years ended December 31,% / point change
In millions2025202420232025 v 20242024 v 2023
Net sales$13.4$29.6$31.5(54.7)%(6.0)%
Adjusted EBITA(2.6)(2.9)(6.5)(10.3)%(55.4)%
Adjusted EBITDA(2.6)(2.9)(4.5)(10.3)%(35.6)%
Adjusted EBITA % of net sales(19.4)%(9.8)%(20.6)%(9.6)10.8
Adjusted EBITDA % of net sales(19.4)%(9.8)%(14.3)%(9.6)4.5

On July 2, 2025, the Company completed the divesture of its Graphic Arts business to Vulcan Metals Specialty Products, Inc., a newly created affiliate of TerraMar Capital LLC. Graphic Arts was previously reported as a separate operating segment under ASC 280. Following the disposal, Graphic Arts will no longer be presented as a reportable segment. The Company recognized a net loss on held-for-sale asset group of $1.9 million in 2025.

31

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility and accompanying ancillary hedging facilities and the Loan Note due in 2026. Our principal liquidity needs are:

•funding acquisitions, including deferred contingent consideration payments;

•capital expenditure requirements;

•payment of shareholder dividends;

•servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the Senior Facilities Agreement;

•working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

•hedging facilities used to manage our foreign exchange risks.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales, in July 2025 we completed a refinance of our shelf facility, the terms of this remaining the same, with expiry now in July 2030. Our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

We have been in compliance with the covenants under the Loan Notes and the RCF throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2025. In July 2025 we completed a refinance of our shelf facility, the terms of this remaining the same, with expiry now in July 2030 as opposed to October 2026.

Luxfer conducts all of its operations through its subsidiaries and joint ventures. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

Cash Flows from Continuing Operations

Operating activities

Cash provided by operating activities was $34.0 million and $51.1 million in 2025 and 2024 respectively, which includes approximately $2.3 million and $5.0 million of cash spent on restructuring activities in those years. Cash was primarily related to the net income from operating activities, net of the following non-cash items: depreciation and amortization; share-based compensation charges; pension credit; gain on disposal of held for sale assets; loss on held-for-sale asset group and net changes to assets and liabilities. In 2025 and 2024 cash flow was positively impacted by the $1.9 million and $5.8 million, respectively, receipt arising from the reimbursement of legal costs in relation to the previously disclosed US Ecology case.

32

Investing activities

Net cash used for investing activities was $4.9 million in 2025, compared to $3.4 million in 2024. The following investing activities impacted our cash flow:

Capital expenditures

Capital expenditures in 2025 was $7.8 million compared to $10.3 million in 2024, with an additional $0.4 million purchasing intangible assets in 2024. We anticipate capital expenditures for 2026 to be between $15 million and $20 million.

Proceeds from assets held for sale

In September 2024, the Company sold a previously held-for-sale building in the Elektron segment for $7.3 million. Consideration was paid in full in October 2024.

Proceeds from sale of businesses

On July 2, 2025, the Company completed the divesture of its Graphic Arts business to Vulcan Metals Specialty Products, Inc., a newly created affiliate of TerraMar Capital LLC, with net proceeds of $2.9 million being received in 2025.

Financing activities

In 2025, net cash used in financing activities was $25.0 million, (2024: $44.0 million). During the year, the Company repaid $3.1 million of bank overdrafts (2024: $1.5 million repaid), made net repayments of $3.2 million on its borrowing facilities (2024: net repayments of $25.7 million) and incurred $0.9 million of costs related to the refinancing of its shelf facility (2024: nil).

Dividend payments totaled $13.9 million in 2025 (2024: $14.0 million), representing $0.52 per ordinary share in both periods

In addition, during 2025, the Company spent $3.1 million repurchasing 246,875 shares, (2024: $2.3 million repurchasing 200,000 shares) and paid $0.8 million in settling share based compensation awards (2024: $0.5 million).

Loan Note 2026

The Note Purchase Agreement contains customary covenants and events of default, in each case with customary and appropriate grace periods and thresholds. In addition, the Note Purchase Agreement requires us to maintain compliance with a minimum interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Note Purchase Agreement) to Net Finance Charges (as defined in the Note Purchase Agreement). We are required to maintain an interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Note Purchase Agreement) to Adjusted Acquisition EBITDA (as defined in the Note Purchase Agreement). We are required to maintain a leverage ratio of no more than 3.0:1. We have been in compliance with the covenants under the Note Purchase Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2025. The Loan Note due 2026 and the Note Purchase Agreement are governed by the law of the State of New York.

The Loan Note due 2026 is denominated in U.S. dollars, which creates a natural partial offset between the dollar-denominated net assets and earnings of our U.S. operations and the dollar-denominated debt and related interest expense of the notes. We have included the Note Purchase Agreement and a form of the Loan Note due 2026 as exhibits to this Annual Report and refer you to the exhibits for more information on the Note Purchase Agreement and the Loan Note due 2026.

Senior Facilities Agreement

Our Senior Facilities Agreement was refinanced in July 2025, for more information see Note 12.

Structure. At December 31, 2025 the Senior Facilities Agreement provided $125 million of committed debt facilities in the form of a multi-currency (GBP sterling, U.S. dollars or euros) RCF and an additional $25 million of uncommitted facilities through an accordion clause. The facilities mature in July 2030. As of December 31, 2025, we had drawn down $15.3 million under the Revolving Credit Facility (December 31, 2024: $17.2 million).

33

Availability. The facility is used for loans and overdrafts. Amounts unutilized under the RCF (or, if the case, under the revolving portion of the accordion) are allocated to ancillary facilities available under the Senior Facilities Agreement in connection with overdraft facilities, bilateral loan facilities and letter of credit facilities. As of December 31, 2025, we had drawn down $3.5 million under the ancillary facilities (December 31, 2024: $2.8 million). We may use amounts drawn under the RCF for our general corporate purposes and certain capital expenditures, as well as for the financing of permitted acquisitions and reorganizations. As of December 31, 2025, $109.7 million (net of $15.3 million drawn down) was available under the RCF. The last month in which we may draw funds from the RCF is June 2030.

The Company also had a separate (uncommitted) bonding facility for bank guarantees; denominated in GBP sterling totaling £0.5 million ($0.7 million) and £0.1 million ($0.2 million) was utilized at December 31, 2025.

Interest rates and fees. Borrowings under the facility bear an interest rate equal to an applicable margin plus either EURIBOR, in the case of amounts drawn in euros, or SONIA (Sterling Overnight Index Average), in the case of amounts drawn in GBP sterling or U.S. dollars.

The tables below sets out the range of ratios and the related margin percentage currently in effect.

LeverageMargin
(% per annum)
Greater than 2.5:12.75
Less than or equal to 2.5:1, but greater than 2.0:12.50
Less than or equal to 2.0:1, but greater than 1.5:12.25
Less than or equal to 1.5:1, but greater than 1.0:12.00
Less than or equal to 1.0:11.75

As of December 31, 2025, we had drawn down $15.3 million under the RCF (December 31, 2024: $17.2 million). A commitment fee is levied each quarter against any unutilized element of the RCF, excluding overdraft or ancillary facilities.

In the event of a sale of all or substantially all of our business and / or assets, or if any person or group of persons acting in concert gains direct or indirect control (as defined in the Senior Facilities Agreement) of Luxfer Holdings PLC, we will be required to immediately repay all outstanding amounts under the RCF (and, if the case, the accordion) and the ancillary facilities under the Senior Facilities Agreement.

In addition, the Senior Facilities Agreement requires us to maintain compliance with an interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Senior Facilities Agreement) to Net Finance Charges (as defined in the Senior Facilities Agreement). We are required to maintain a minimum interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Senior Facilities Agreement) to the Relevant Period Adjusted Acquisition EBITDA (as defined in the Senior Facilities Agreement). We are required to maintain a leverage ratio of no more than 3.0:1.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2025.

The Senior Facilities Agreement is governed by English law. For more information see ITEM 8, Note 12.

Dividends

We paid dividends in 2025 of $13.9 million (2024: $14.0 million), or $0.52 per share in both years

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and the International Accounting Standards Board, which differ in some respects from U.S. GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

34

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

Payments Due by Period
In millionsTotalLess than 1 year1 – 3 years3 – 5 yearsAfter 5 years
Contractual cash obligations
Loan Notes due 2026$25.0$25.0$$$
Revolving Credit Facility due July 203015.315.3
Obligations under operating leases17.74.63.52.17.5
Capital commitments2.22.2
Interest payments4.61.51.71.4
Total contractual cash obligations$64.8$33.3$5.2$18.8$7.5

2024 compared with 2023

For a discussion comparing our net cash activities (operating, investing and financing) for the year ended December 31, 2024, with the year ended December 31, 2023, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the U.S. Securities and Exchange Commission on February 25, 2025. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2025.

Off-balance sheet measures

At December 31, 2025, we had no off-balance sheet arrangements other than the three bonding facilities as described above.

COMMITMENTS AND CONTINGENCIES

Capital commitments

At December 31, 2025, the Company had capital expenditure commitments of $2.2 million (2024: $0.5 million and 2023: $2.3 million) for the purchase of new plant and equipment.

Committed banking facilities

At December 31, 2025 and December 31, 2024 the Company had committed banking facilities of $125.0 million with an additional $25.0 million of uncommitted facilities through an accordion provision. Of these committed facilities, $15.3 million was drawn at December 31, 2025 ($17.2 million December 31, 2024). The banking facilities expire in October 2026.

Contingencies

In December 2023, it was established that any potential liability arising from the lawsuits and reasonable defense costs related to the previously disclosed US Ecology case are covered by insurance. The Company recognized $7.7 million in the twelve months of 2024, in relation to recovery of these costs previously incurred by the Company. $5.8 million cash was received in 2024 with a further $1.9 million received in 2025.

In January 2025, a final settlement was agreed upon related to the US Ecology case which was covered in full by the Company's insurance policy, with payment received in February 2025. As a result, the Company recorded a liability for the settlement in other current liabilities and recognized a gain contingency related to the insurance payout receivable in accounts and other receivables as at December 31, 2024, nil at December 31, 2025.

In April 2025, the Office of Defects Investigation (ODI) of the National Highway Traffic Safety Administration (NHTSA) opened a Preliminary Evaluation to investigate allegations of compressed natural gas (CNG) fuel leaks in certain CNG fuel systems, equipped with certain Luxfer Type 4 CNG fuel containers. Luxfer is fully co-operating with this Preliminary Evaluation, which has a range of potential outcomes, and at this stage Luxfer is not able to estimate the potential financial impact. Luxfer does not believe that this alleged issue poses an unreasonable risk to motor vehicle safety.

In July 2025, in accordance with the Luxfer Graphic Arts sale agreement, the Company has fully indemnified the purchaser for certain identified environmental matters relating to the Madison Illinois site, which we estimate will cost approximately $1.0 million to close out. A provision for these obligations has been recognized and is included within other current liabilities in the Consolidated Balance Sheet.

35

Additionally, we have provided indemnification for any unidentified environmental matters that may have occurred between 2003 (the year of the original acquisition by Luxfer) and July 2025, capped at $10.0 million and / or 5 years.

Also, in 2025, the Company recognized a provision in relation to dilapidation obligations associated with the former Superform U.K. site sold in 2021, for which the Group remains a guarantor under the relevant lease arrangements following disposal of the business. The obligation reflects management’s best estimate of the costs required to settle the remaining property reinstatement and exit obligations.

NEW ACCOUNTING STANDARDS

See ITEM 8, Note 1 of the notes to the Consolidated Financial Statements, included in this Form 10-K, for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

CRITICAL ACCOUNTING ESTIMATES

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Our significant accounting policies are more fully described in ITEM 8, Note 1 of the Notes to Consolidated Financial Statements. Certain accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, terms of existing contracts, our observance of trends in the industry and information available from other outside sources, as appropriate. We consider an accounting estimate to be critical if:

•it requires us to make assumptions about matters that were uncertain at the time we were making the estimate; and

•changes in the estimate or different estimates that we could have selected would have had a material impact on our financial condition or results of operations.

Our critical accounting estimates include the following:

U.K. Defined Benefit Pension Plan

The Company operates a funded defined benefit pension plan in the U.K., and immaterial plans in the U.S. and France. The amounts recognized in our consolidated financial statements related to our defined-benefit pension and other post-retirement plans are determined from actuarial valuations. Inherent in these valuations are assumptions, including: (i) discount rates; (ii) inflation rates; (iii) pension increases; and (iv) life expectancy. These assumptions are updated annually and are disclosed in ITEM 8, Note 15 to the Notes to Consolidated Financial Statements. Differences in actual experience or changes in assumptions can have a material impact on the pension and other post-retirement obligations and future expense.

We recognize changes in the fair value of plan assets and net actuarial gains or losses for pension and other post-retirement benefits annually in the fourth quarter each year ("mark-to-market adjustment") and, if applicable, in any quarter in which an interim remeasurement is triggered. Net actuarial gains and losses occur when the actual experience differs from any of the various assumptions used to value our pension and other post-retirement plans or when assumptions change as they may each year. The primary factors contributing to actuarial gains and losses each year are (i) changes in the discount rate used to value pension and other post-retirement benefit obligations as of the measurement date and (ii) differences between the expected and the actual return on plan assets. This accounting method also results in the potential for volatile and difficult to forecast mark-to-market adjustments. The remaining components of pension expense, including service and interest costs and the expected return on plan assets, are recorded on a quarterly basis as ongoing pension expense. The latest triennial actuarial valuation of the Plan was carried out in March 31, 2024, the Plan had a surplus of £20.8 million (compared with a £12.2 million deficit at the previous valuation in April 2021).

Discount rate

The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. This yield produced a weighted-average discount rate for our U.K. plans of 5.50% in 2025, 5.40% in 2024 and 4.50% in 2023. The discount rate on our U.S. plans was n/a in 2025, 2024, and 2023. There are no known or anticipated changes in our discount rate assumption that will impact our pension expense in 2025.

To indicate the sensitivity of results to this assumption, a 0.1% per annum increase in the discount rate for our U.K. plans would reduce the value of the liabilities and therefore increase the pension surplus by approximately $2.7 million and result in the projected 2026 income statement credit being broadly unchanged.

Inflation rate

36

In September 2019, the UK Statistics Authority announced plans to reform the RPI inflation index. On November 25, 2020, the government and UK Statistics Authority confirmed these plans to reform the RPI index to bring it into line with the CPIH index from 2030, with no compensation for the holders of index-linked gilts. Inflation measured by the CPIH is consistently significantly lower than that measured by RPI, and therefore, these plans imply a significant expected reduction in RPI inflation from 2030 onwards. As a result we have taken a stepped approach and used different inflation rates pre and post 2030.

To indicate the sensitivity of results to the CPI assumption, a 0.1% per annum decrease in all CPI-linked assumptions, (including pension increases) for our U.K. plan, would reduce the value of the liabilities and therefore increase the pension surplus at December 31, 2025 by approximately $1.3 million and increase the projected 2026 income statement credit by approximately $0.1 million.

Pension increases

The pension increase assumptions have been set with reference to the corresponding CPI inflation assumption and take account of the caps and floors applicable to the various components of pension indexation.

Life expectancy

The life expectancies of male and female members aged 65 on 31 December 2025 are assumed to be 20.2 and 22.8 years, respectively, with the life expectancies of male and female members aged 65 on 31 December 2045 assumed to be 21.4 and 24.2 years, respectively.

To indicate the sensitivity of results to the life expectancy assumption, a one year increase in assumed life expectancy on the U.K. plan could increase the value of the liabilities and therefore decrease the pension surplus at December 31, 2025 by approximately $6.7 million and decrease the projected 2026 income statement credit by approximately $0.7 million.

Expected rate of return

Our expected rate of return on plan assets for our U.K. plans was 5.30% in 2025, 5.80% in 2024 and 4.80% in 2023. The expected rate of return on our U.S. plans was n/a in 2025, 2024, and 2023. The expected rate of return is designed to be a long-term assumption that may be subject to considerable year-to-year variance from actual returns. In developing the expected long-term rate of return, we considered our historical returns, with consideration given to forecast economic conditions, our asset allocations, input from external consultants and broader longer-term market indices.

See ITEM 8, Note 15 of the Notes to Consolidated Financial Statements for further information regarding pension and other post-retirement plans.

37

MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. The latest 10-K appears above; prior years are below.

FY 2024 10-K MD&A

SEC filing source: 0001096056-25-000015.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2025-02-25. Report date: 2024-12-31.

Item 7.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Annual Report on Form 10-K contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Annual Report, as well as:

•general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

•worldwide economic and business conditions and conditions in the industries in which we operate;

•potential or actual tariffs, and other political risks worldwide;

•our ability to execute our strategic review, including our Graphic Arts business, to safeguard margins and reduce costs;

•future pandemics;

•fluctuations in the cost and / or availability of raw materials, labor and energy, as well as our ability to pass on cost increases to customers;

•currency fluctuations and other financial risks;

•our ability to protect our intellectual property;

•the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

•relationships with our customers and suppliers;

•increased competition from other companies in the industries in which we operate;

•changing technology;

•our ability to execute and integrate new acquisitions;

•claims for personal injury, death or property damage arising from the use of products produced by us;

•the occurrence of accidents or other interruptions to our production processes;

•changes in our business strategy or development plans, and our expected level of capital expenditure;

•our ability to attract and retain qualified personnel;

•restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

•climate change regulations and the potential impact on energy costs;

•regulatory, environmental, legislative and judicial developments; and

•our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," of this Annual Report on Form 10-K for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

28

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Luxfer is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Key trends and uncertainties regarding our existing business

Uncertainty of demand in certain end-markets

Macro-economic conditions have continued to impact our general industrial end-market with demand remaining soft for products across all segments. We have also experienced variability of demand for certain products in our defense, first response & healthcare end-market, particularly defense applications, including countermeasure flares and flameless ration heaters, although we have seen this improve in the second half of the year. We have been able to navigate these challenges through productivity and cost management initiatives resulting in improved margins. Legal recoveries and effective working capital management contributed to excellent cash conversion and significantly reduced net debt levels.

While the outlook remains uncertain there are some signs of recovery within the industrial and defense end markets within our Elektron segment, which we are well-placed to capitalize on.

Operating objectives and trends

In 2025, we expect the following operating objectives and trends to impact our business:

•Addressing continuing general macro uncertainty and building resilience into the outlook;

•Ongoing focus on cost control and productivity improvements across the business to drive margin improvement, as well as new product launches to stimulate top line growth;

•Execution of actions identified upon completion of the previously announced expanded and accelerated strategic review, including the divestiture of Graphic Arts and Superform U.S.;

•Execution of selected capital investment projects to support our strategy of profitable growth while maintaining our infrastructure;

•Continued emphasis on operating cash generation and maintaining strong working capital performance;

•Further improvements in ESG standing through focus on sustainability and on our values of teamworking and accountability; and

•Focus on recruiting, developing and maintaining talent, while driving a high-performance culture.

29

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations from continuing operations of Luxfer were as follows:

Years ended December 31,% / point change
In millions2024202320222024 v 20232023 v 2022
Net sales$391.9$405.0$423.4(3.2)%(4.3)%
Cost of sales(306.2)(328.4)(328.4)(6.8)%%
Gross profit85.776.695.011.9%(19.4)%
% of net sales21.9%18.9%22.4%3.0(3.5)
Selling, general and administrative expenses(48.1)(48.7)(43.1)(1.2)%13.0%
% of net sales12.3%12.0%10.2%0.31.8
Research and development(4.4)(4.6)(4.9)(4.3)%(6.1)%
% of net sales1.1%1.1%1.2%(0.1)
Restructuring charges(4.7)(6.4)(1.9)(26.6)%236.8%
% of net sales1.2%1.6%0.4%(0.4)1.2
Impairment charges(12.7)(100.0)%n/a
% of net sales%3.1%%(3.1)3.1
Acquisition and disposals costs(12.2)(0.3)n/a(100.0)%
% of net sales3.1%%0.1%3.1(0.1)
Other income7.7n/an/a
% of net sales2.0%%%2.0
Gain on disposal of assets held-for-sale6.1n/an/a
% of net sales(1.6)%%%(1.6)
Operating income30.14.244.8616.7%(90.6)%
% of net sales7.7%1.0%10.6%6.7(9.6)
Net interest expense(5.2)(6.3)(3.9)(17.5)%61.5%
% of net sales1.3%1.6%0.9%(0.3)0.7
Defined benefit pension credit / (charge)1.6(7.6)0.1(121.1)%(7,700.0)%
% of net sales0.4%(1.9)%%2.3(1.9)
Income / (loss) before income taxes26.5(9.7)41.0(373.2)%(123.7)%
% of net sales6.8%(2.4)%9.7%9.2(12.1)
(Provision) / credit for income taxes(8.2)7.1(9.0)(215.5)%(178.9)%
Effective tax rate30.9%73.2%22.0%(42.3)51.2
Net income / (loss) from continuing operations$18.3$(2.6)$32.0(803.8)%(108.1)%
% of net sales4.7%(0.6)%7.6%5.3(8.2)

30

Net sales

Adjusting for foreign exchange tailwinds of $1.7 million (2023: $0.3 million), consolidated net sales have decreased by 3.6% in 2024 from 2023. The adverse impact of volume and mix has accounted for a $16.0 million reduction in sales, while the passing through of price increases has slightly offset this decrease by $1.2 million.

While sales in our General Industrial and Transportation end markets have decreased by 9.2% and 5.7% respectively, our sales in our Defense, First Response and Healthcare end market have increased by 2.7%.

Overall sales have been negatively impacted by:

•Significant decrease in demand for zirconium products, particularly those used in automotive catalysis products;

•Lower sales of both commercial and defense aerospace alloys;

•Reductions in sales of chemical response kits following increased activity in the prior year clearing order backlogs;

•Lower sales for Alternative Fuel cylinders following lower demand in North America; and

•Decreased demand for photo-engraving plates.

These decreases were partially offset by:

•Increased sales of flameless ration heaters for meals ready to eat (MRE) and of our new unitized ration product ("UGR-E") ;

•Strong sales of magnesium alloys, particularly those used in automotive applications; and

•Stronger demand for SCBA cylinders as well as cylinders used in aerospace applications.

Gross profit

The 3.0 percentage point increase in gross profit as a percentage of sales in 2024 from 2023 was primarily the result of contract renegotiation and manufacturing efficiencies having a positive impact on margins within the Gas Cylinders and Elektron Divisions respectively. This has been partially offset by adverse volume and mix.

Selling, general and administrative expenses ("SG&A")

SG&A costs as a percentage of sales are relatively flat, having increased by 0.3 percentage points in 2024 from 2023. SG&A costs in 2023 included $5.9 million of legal costs in the Elektron Division. This activity relates to the legal case described in Note 22.

Research and development costs

Research and development costs as a percentage of sales remained flat in 2024 when compared to 2023 the overall spend of $4.4 million continues to show our commitment to new product development.

Restructuring charges

The $4.7 million restructuring charges in 2024 includes:

•$1.9 million of asset impairments and $1.8 million asset relocation, restructuring and other costs in relation to the rationalization of our North American Gas Cylinders businesses to reduce our fixed cost base;

•$0.1 million gain on disposal of Luxfer Gas Cylinders France site, offset by $0.9 million of costs incurred in relation to its closure; and

•$0.2 million of waste clean up costs in the Elektron division in relation to the consolidation of production facilities in the Magnesium Powders operations.

31

Impairment charges

The $12.7 million impairment charges incurred in 2023 arose from fully writing down property, plant and equipment and right of use assets from operating leases within our Graphic Arts division as a result of our annual impairment and strategic review.

Acquisition and disposals costs

In 2024 acquisition and disposal related costs of $12.2 million were incurred in relation to the divestiture of our Graphic Arts segment. $9.8 million represents a loss on held-for-sale asset group to reflect its fair value and $2.4 million represents professional fees. No acquisition and disposal related costs were incurred during 2023.

Other Income

Other Income of $7.7 million in 2024 relates to the recovery of legal costs from our insurer related to the previously disclosed US Ecology case, (see Note 22). Historically the legal costs relating to this case were in selling, general and administrative expenses. There was no other income in 2023.

Gain on Disposal of assets held for sale

The $6.1 million gain on disposal recognized in 2024 was in relation to the sale of previously disclosed held-for-sale land and buildings in our Elektron division. Net consideration of $7.3 million was received in the fourth quarter of 2024. There was no gain on disposal of assets held for sale in 2023.

Net interest expense

Net interest expense of $5.2 million in 2024 decreasing from $6.3 million in 2023 primarily due to the lower average drawings on the revolving credit facility.

Defined benefit pension credit

The defined benefit pension credit of $1.6 million in 2024, is in relation to the U.K. plan.

The defined benefit pension charge of $7.6 million in 2023, was predominantly the result of the sale of the U.S. pension plan liability to an insurer. There was a $9.0 million charge in relation to the sale, which included $2.1 million cash and $6.9 million in relation to the derecognition of the U.S. pension liability and reallocation of accumulated actuarial losses from other comprehensive income. An additional $0.3 million of interest cost was recognized in relation to the U.S. plan in the year. The 2023 charge was partially offset by a $1.7 million credit on the U.K. plan as expected return on assets outweighed the interest cost and net actuarial loss. This is consistent with the current year.

Provision for income taxes

The 42.3 percentage point decrease in the effective tax rate in 2024 from 2023 was primarily due to non-deductible expenses and deferred tax credit, predominantly in relation to the previously mentioned pension buy-out and impairment charges.

2023 compared with 2022

For a discussion comparing our consolidated operating results for the year ended December 31, 2023, with the year ended December 31, 2022, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the U.S. Securities and Exchange Commission on February 27, 2024. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2024.

32

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following tables of non-GAAP summary financial data presents a reconciliation of net income from continuing operations and diluted earnings per ordinary share from continuing operations to adjusted net income from continuing operations, adjusted EBITA from continuing operations, adjusted income from continuing operations before income taxes, adjusted EBITDA from continuing operations, adjusted EBITDA excluding legal cost (recovery) / expense, adjusted earnings per ordinary share from continuing operations, adjusted provision for income taxes and adjusted effective tax rate from continuing operations, for the periods presented, being the most comparable GAAP measures. Management believes that adjusted net income excluding legal cost (recovery) / expense, adjusted earnings per share, adjusted EBITA and adjusted EBITDA excluding legal cost (recovery) / expense are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income from continuing operations, adjusted earnings per share from continuing operations, adjusted EBITA from continuing operations and adjusted EBITDA excluding legal cost (recovery) / expense from continuing operations in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability. In 2024, the Company initiated a process to divest the Graphic Arts business. While Graphic Arts does not meet the 'strategic shift' criteria outlined in ASC 205-20 for it to be classified as a discontinued operation, we believe that given the expectation that divestiture will be completed in the current year, it is appropriate in the tables below to separate out the results of Graphic Arts in order to provide a more complete financial summary for the period. Similarly for other Income of $7.7 million in 2024 relates to the recovery of legal costs from our insurer related to the previously disclosed US Ecology case, historically the legal costs relating to this case were in selling, general and administrative expenses, however the other income in 2024 is separated due to its one-off nature and the recovery relating to several years. We believe separating the income and costs relating to this is also appropriate to provide a more complete financial summary for the period.

Year-to-date
In millions except per share data20242023
Continuing operationsGraphic ArtsAdjusted TotalContinuing operationsGraphic ArtsAdjusted Total
Net income / (loss)$18.3$(13.9)$32.2$(2.6)(14.9)$12.3
Accounting charges relating to acquisitions and disposals of businesses:
Amortization on acquired intangibles0.80.80.80.8
Acquisition and disposal related charge12.212.2
Defined benefit pension (credit) / charge(1.6)(1.6)7.67.6
Restructuring charge4.74.76.46.4
Gain on disposal of assets held-for-sale(6.1)(6.1)
Impairment charge12.712.7
Share-based compensation charge3.50.53.02.82.8
Tax impact of defined benefit settlement(4.9)(4.9)
Income tax on adjusted items(0.9)(0.6)(0.3)(6.4)(3.0)(3.4)
Adjusted net income / (loss)30.9(1.8)32.716.4(5.2)21.6
Less:
Legal cost (recovery) / expense(7.7)(7.7)5.95.9
Tax on legal cost recovery / (expense)1.81.8(1.2)(1.2)
Adjusted net income / (loss) excluding legal cost (recovery) / expense$25.0$(1.8)$26.8$21.1$(5.2)$26.3
Adjusted earnings / (loss) per ordinary share (1)
Diluted earnings / (loss) per ordinary share$0.68$(0.51)$1.19$(0.10)$(0.55)$0.45
Impact of adjusted items0.460.440.020.710.360.35
Adjusted diluted earnings / (loss) per ordinary share$1.14$(0.07)$1.21$0.61$(0.19)$0.80
Impact of legal cost (recovery) / expense(0.22)(0.22)0.170.17
Adjusted diluted earnings / (loss) per ordinary share excluding legal cost recovery / expense$0.92$(0.07)$0.99$0.78$(0.19)$0.97

(1) For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees.

33

Year-to-date
In millions except per share data20242023
Continuing operationsGraphic ArtsAdjusted TotalContinuing operationsGraphic ArtsAdjusted Total
Adjusted net income from continuing operations$30.9$(1.8)$32.7$16.4$(5.2)$21.6
Add back:
Income tax on adjusted items0.90.60.36.43.03.4
Income tax expense8.2(1.3)9.5(7.1)(4.1)(3.0)
Tax impact of defined benefit pension settlement4.94.9
Net finance costs5.2(0.4)5.66.3(0.2)6.5
Adjusted EBITA45.2(2.9)48.126.9(6.5)33.4
Loss on disposal of property, plant and equipment0.10.1
Depreciation9.39.311.92.09.9
Adjusted EBITDA54.6(2.9)57.538.8(4.5)43.3
Less:
Legal cost (recovery) / expense(7.7)(7.7)5.95.9
Adjusted EBITDA excluding legal cost (recovery) / expense$46.9$(2.9)$49.8$44.7$(4.5)$49.2
Year-to-date
In millions except per share data20242023
Continuing operationsGraphic ArtsAdjusted TotalContinuing operationsGraphic ArtsAdjusted Total
Adjusted net income / (loss) from continuing operations$30.9$(1.8)$32.7$16.4$(5.2)$21.6
Add back:
Income tax on adjusted items0.90.60.36.43.03.4
Tax impact of defined benefit pension settlement4.94.9
Provision / (credit) for income taxes8.2(1.3)9.5(7.1)(4.1)(3.0)
Adjusted income / (loss) from continuing operations before income taxes40.0(2.5)42.520.6(6.3)26.9
Adjusted provision (credit) for income taxes9.1(0.7)9.84.2(1.1)5.3
Adjusted effective tax rate from continuing operations22.8%28.0%23.1%20.4%17.5%19.7%
2024
In millionsGas CylindersElektronGraphic ArtsTotal
Segment adjusted EBITA$14.6$33.5$(2.9)$45.2
Depreciation3.45.99.3
Loss on disposal of property, plant and equipment0.10.1
Segment adjusted EBITDA$18.0$39.5$(2.9)$54.6
2023
In millionsGas CylindersElektronGraphic ArtsTotal
Segment adjusted EBITA$12.6$20.8$(6.5)$26.9
Depreciation4.15.82.0$11.9
Segment adjusted EBITDA$16.7$26.6$(4.5)$38.8
2022
In millionsGas CylindersElektronGraphic ArtsTotal
Segment adjusted EBITA$8.0$36.6$5.6$50.2
Depreciation4.85.92.212.9
Segment adjusted EBITDA$12.8$42.5$7.8$63.1

34

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our three reportable segments (Gas Cylinders, Elektron and Graphic Arts). The three segments comprise various product offerings that serve multiple end-markets.

In 2023, the Graphic Arts reporting segment was disaggregated from the Elektron segment and in 2024 and 2023 is being reported separately as the Graphic Arts segment. The Elektron segment's results for 2022 have been adjusted to strip out Graphic Arts' results.

Adjusted EBITA, which is our segment income metric, represents net income from continuing operations adjusted for share-based compensation charges, restructuring charges, impairment charges, other charges, acquisitions and disposals costs, net interest expenses, defined benefits pension credit, provision for taxes and amortization. A reconciliation to pre-tax income can be found in ITEM 8, Note 18. Adjusted EBITDA, as shown below, represents adjusted EBITA less depreciation. Management believes that adjusted EBITA and adjusted EBITDA are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. Adjusted EBITDA is reconciled to adjusted EBITA above.

GAS CYLINDERS

The results of operations from the Gas Cylinders segment are for continuing operations only.

The net sales, adjusted EBITA and adjusted EBITDA for Gas Cylinders were as follows:

Years ended December 31,% / point change
In millions2024202320222024 v 20232023 v 2022
Net sales$186.3$186.4$183.7(0.1)%1.5%
Adjusted EBITA14.612.68.015.9%57.5%
Adjusted EBITDA18.016.712.87.8%30.5%
Adjusted EBITA % of net sales7.8%6.8%4.4%1.02.4
Adjusted EBITDA % of net sales9.7%9.0%7.0%0.72.0

Net sales

The 0.1% decrease in Gas Cylinders sales in 2024 from 2023 was primarily the result of:

•Lower sales of Alternative Fuels cylinders;

•Industrial cylinders' sales being weaker in the year.

These increases have been largely offset by:

•Price increases throughout the segment as contracts are renegotiated; and

•Increased volumes of our medical and aerospace cylinders.

Adjusted EBITA

The 1.0 percentage point increase in adjusted EBITA for Gas Cylinders as a percentage of net sales in 2024 from 2023 is predominantly the result of pricing improvements from new sales contracts partially offset by adverse sales mix and volume.

Adjusted EBITDA

The 0.7 percentage point increase in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2024 from 2023 is predominantly the result of the increase in adjusted EBITA as a percentage of net sales.

35

ELEKTRON

The net sales, adjusted EBITA and adjusted EBITDA for Elektron were as follows:

Years ended December 31,% / point change
In millions2024202320222024 v 20232023 v 2022
Net sales$176.0$187.1$201.0(5.9)%(6.9)%
Adjusted EBITA33.520.836.661.1%(43.2)%
Adjusted EBITDA39.526.642.548.5%(37.4)%
Adjusted EBITA % of net sales19.0%11.1%18.2%7.9(7.1)
Adjusted EBITDA % of net sales22.4%14.2%21.1%8.2(6.9)

Net sales

The 5.9% decrease in Elektron sales in 2024 from 2023 was primarily the result of:

•Significant decrease in demand for zirconium products, particularly those used in automotive catalysis products;

•Lower sales of both commercial and defense aerospace alloys; and

•Reductions in chemical response kit and commercial magnesium powder sales.

These decreases were partially offset by:

•Increased sales of flameless ration heaters for meals ready to eat (MRE) and of our new unitized ration product ("UGR-E") ;

•Strong sales of magnesium alloys, particularly those used in automotive applications;

•Increased magnesium alloy sales to the Oil and Gas industry.

Adjusted EBITA

The 7.9 percentage point increase in adjusted EBITA for Elektron as a percentage of net sales in 2024 from 2023 was a result of the net recovery from the previously disclosed US Ecology case in 2024 of $7.7 million, compared to the net cost of $5.9 million in 2023. This was partially offset by adverse price.

Adjusted EBITDA

The 8.2 percentage point increase in adjusted EBITDA for Elektron as a percentage of net sales in 2024 from 2023 was predominantly the result of the increase in adjusted EBITA as a percentage of net sales.

GRAPHIC ARTS

The net sales, adjusted EBITA and adjusted EBITDA for Graphic Arts were as follows:

Years ended December 31,% / point change
In millions2024202320222024 v 20232023 v 2022
Net sales$29.6$31.5$38.7(6.0)%(18.6)%
Adjusted EBITA(2.9)(6.5)5.6(55.4)%(216.1)%
Adjusted EBITDA(2.9)(4.5)7.8(35.6)%(157.7)%
Adjusted EBITA % of net sales(9.8)%(20.6)%14.5%10.8(35.1)
Adjusted EBITDA % of net sales(9.8)%(14.3)%20.2%4.5(34.5)

Net sales

The 6.0% decrease in Graphic Arts sales in 2024 from 2023 was primarily the result of fluctuating demand for photo-engraving plates, particularly outside the North American market.

Adjusted EBITA

The loss in 2024 for Graphic Arts was a result of relatively high magnesium raw material cost amid increased competition. 2023 was significantly impacted by significant material cost inflation resulting in competitive constraints. Magnesium purchase price has reduced throughout 2024, although there is typically a lag before this impact is recognized in the income statement through lower cost of sales.

Adjusted EBITDA

The loss in 2024 for Graphic Arts was a result of the factors above, in accordance with ASC 360, depreciation did not impact 2024 as no depreciation is charged on assets held for sale.

36

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility and accompanying ancillary hedging facilities and the Loan Note due in 2026. Our principal liquidity needs are:

•funding acquisitions, including deferred contingent consideration payments;

•capital expenditure requirements;

•payment of shareholder dividends;

•servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the Senior Facilities Agreement;

•working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

•hedging facilities used to manage our foreign exchange risks and aluminum purchase price risks.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales. Also, our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

We have been in compliance with the covenants under the Loan Notes and the RCF throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2024.

Luxfer conducts all of its operations through its subsidiaries, joint ventures and affiliates. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

Cash Flows from Continuing Operations

Operating activities

Cash provided by operating activities was $51.1 million and $26.2 million in 2024 and 2023 respectively, which includes approximately $5.0 million and $3.6 million of cash spent on restructuring activities in those years. Cash was primarily related to the net income / loss from operating activities, net of the following non-cash items: depreciation and amortization; share-based compensation charges; pension credit / (charge); gain on disposal of held for sale assets; loss on held-for-sale asset group and net changes to assets and liabilities. Cash flow was impacted by the $5.8 million receipt arising from the reimbursement of legal costs in relation to the previously disclosed US Ecology case, whereas 2023 had an outflow of $5.9 million. Also impacting the 2023 cash flow was the $2.1 million contribution the Company made in relation to the sale of the U.S. pension plan to an insurer.

Investing activities

Net cash used for investing activities was $3.4 million in 2024, compared to $9.4 million in 2023. The following investing activities impacted our cash flow:

Capital expenditures

37

Capital expenditures in 2024 was $10.3 million compared to $9.4 million in 2023. We anticipate capital expenditures for 2025 to be between $12 million and $15 million as we increase investment in order to grow the business.

Proceeds from assets held for sale

In September 2024, the Company sold a previously held-for-sale building in the Elektron segment for $7.3 million. Consideration was paid in full in October 2024.

Financing activities

In 2024, net cash used for financing activities was $44.0 million, (2023: $27.5 million). We repaid $1.5 million of bank overdraft, made net repayments on our borrowing facilities of $25.7 million (2023: net drawdowns of $10.2 million) and dividend payments of $14.0 million (2023: $14.0 million), equating to $0.52 per ordinary share (2023: $0.52 per ordinary share). In 2024, the Company spent $2.3 million repurchasing approximately 200,000 shares, (2023: $2.7 million repurchasing approximately 200,000 shares).

Loan Note 2026

The Note Purchase Agreement contains customary covenants and events of default, in each case with customary and appropriate grace periods and thresholds. In addition, the Note Purchase Agreement requires us to maintain compliance with a minimum interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Note Purchase Agreement) to Net Finance Charges (as defined in the Note Purchase Agreement). We are required to maintain an interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Note Purchase Agreement) to Adjusted Acquisition EBITDA (as defined in the Note Purchase Agreement). We are required to maintain a leverage ratio of no more than 3.0:1. We have been in compliance with the covenants under the Note Purchase Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2024. The Loan Note due 2026 and the Note Purchase Agreement are governed by the law of the State of New York.

The Loan Note due 2026 is denominated in U.S. dollars, which creates a natural partial offset between the dollar-denominated net assets and earnings of our U.S. operations and the dollar-denominated debt and related interest expense of the notes. We have included the Note Purchase Agreement and a form of the Loan Note due 2026 as exhibits to this Annual Report and refer you to the exhibits for more information on the Note Purchase Agreement and the Loan Note due 2026.

Senior Facilities Agreement

A Senior Facilities Agreement was signed in October 2021, for more information see ITEM 8 Note 12.

Structure. At December 31, 2024 the Senior Facilities Agreement provided $125 million of committed debt facilities in the form of a multi-currency (GBP sterling, U.S. dollars or euros) RCF and an additional $25 million of uncommitted facilities through an accordion clause. The facilities mature in October 2026. As of December 31, 2024, we had drawn down $17.2 million under the Revolving Credit Facility (December 31, 2023: $43.1 million).

38

Availability.    The facility is used for loans and overdrafts. Amounts unutilized under the RCF (or, if the case, under the revolving portion of the accordion) are allocated to ancillary facilities available under the Senior Facilities Agreement in connection with overdraft facilities, bilateral loan facilities and letter of credit facilities. As of December 31, 2024, we had drawn down $2.8 million under the ancillary facilities (December 31, 2023: $2.2 million). We may use amounts drawn under the RCF for our general corporate purposes and certain capital expenditures, as well as for the financing of permitted acquisitions and reorganizations. As of December 31, 2024, $107.8 million (net of $17.2 million drawn down) was available under the RCF. The last month in which we may draw funds from the RCF is September 2026.

The Company also had a separate (uncommitted) bonding facility for bank guarantees; denominated in GBP sterling totaling £0.5 million ($0.6 million) and £0.1 million ($0.2 million) was utilized at December 31, 2024.

Interest rates and fees.    Borrowings under the facility bear an interest rate equal to an applicable margin plus either EURIBOR, in the case of amounts drawn in euros, or SONIA (Sterling Overnight Index Average), in the case of amounts drawn in GBP sterling or U.S. dollars.

The tables below sets out the range of ratios and the related margin percentage currently in effect.

LeverageMargin
(% per annum)
Greater than 2.5:12.75
Less than or equal to 2.5:1, but greater than 2.0:12.50
Less than or equal to 2.0:1, but greater than 1.5:12.25
Less than or equal to 1.5:1, but greater than 1.0:12.00
Less than or equal to 1.0:11.75

As of December 31, 2024, we had drawn down $17.2 million under the RCF (December 31, 2023: $43.1 million). A commitment fee is levied each quarter against any unutilized element of the RCF, excluding overdraft or ancillary facilities.

In the event of a sale of all or substantially all of our business and / or assets, or if any person or group of persons acting in concert gains direct or indirect control (as defined in the Senior Facilities Agreement) of Luxfer Holdings PLC, we will be required to immediately repay all outstanding amounts under the RCF (and, if the case, the accordion) and the ancillary facilities under the Senior Facilities Agreement.

In addition, the Senior Facilities Agreement requires us to maintain compliance with an interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Senior Facilities Agreement) to Net Finance Charges (as defined in the Senior Facilities Agreement). We are required to maintain a minimum interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Senior Facilities Agreement) to the Relevant Period Adjusted Acquisition EBITDA (as defined in the Senior Facilities Agreement). We are required to maintain a leverage ratio of no more than 3.0:1.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2024.

The Senior Facilities Agreement is governed by English law. For more information see ITEM 8, Note 12.

Dividends

We paid dividends in 2024 of $14.0 million (2023: $14.0 million), or $0.52 (2023: $0.52) per ordinary share.

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and the International Accounting Standards Board, which differ in some respects from U.S. GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

39

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

Payments Due by Period
In millionsTotalLess than 1 year1 – 3 years3 – 5 yearsAfter 5 years
Contractual cash obligations
Loan Notes due 2026$25.0$$25.0$$
Revolving Credit Facility due October 202617.217.2
Bank overdraft3.13.1
Obligations under operating leases20.24.65.72.27.7
Capital commitments0.50.5
Interest payments3.72.31.4
Total contractual cash obligations$69.7$10.5$49.3$2.2$7.7

2023 compared with 2022

For a discussion comparing our net cash activities (operating, investing and financing) for the year ended December 31, 2023, with the year ended December 31, 2022, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the U.S. Securities and Exchange Commission on February 27, 2024. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2024.

Off-balance sheet measures

At December 31, 2024, we had no off-balance sheet arrangements other than the three bonding facilities as described above.

COMMITMENTS AND CONTINGENCIES

Capital commitments

At December 31, 2024, the Company had capital expenditure commitments of $0.5 million (2023: $2.3 million and 2022: $1.4 million) for the purchase of new plant and equipment.

Committed banking facilities

At December 31, 2024 and December 31, 2023 the Company had committed banking facilities of $125.0 million with an additional $25.0 million of uncommitted facilities through an accordion provision. Of these committed facilities, $17.2 million was drawn at December 31, 2024 ($43.1 million December 31, 2023). The banking facilities expire in October 2026.

Contingencies

In December 2023, it was established that any potential liability arising from the lawsuits and reasonable defense costs related to the US Ecology case (see Note 22) are covered by insurance. The Company recognized $7.7 million within other income in the twelve months of 2024, in relation to these costs previously incurred by the Company. $5.8 million cash has been received in 2024 and a final $1.9 million has been received post year end, included within accounts and other receivables.

NEW ACCOUNTING STANDARDS

See ITEM 8, Note 1 of the notes to the Consolidated Financial Statements, included in this Form 10-K, for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

40

CRITICAL ACCOUNTING ESTIMATES

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Our significant accounting policies are more fully described in ITEM 8, Note 1 of the Notes to Consolidated Financial Statements. Certain accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, terms of existing contracts, our observance of trends in the industry and information available from other outside sources, as appropriate. We consider an accounting estimate to be critical if:

•it requires us to make assumptions about matters that were uncertain at the time we were making the estimate; and

•changes in the estimate or different estimates that we could have selected would have had a material impact on our financial condition or results of operations.

Our critical accounting estimates include the following:

Impairment of goodwill

Goodwill

Goodwill represents the excess of the cost of acquired businesses over the net of the fair value of identifiable net assets purchased and liabilities assumed.

Goodwill is tested at least annually for impairment and is tested for impairment more frequently if events or changes in circumstances indicate that the asset might be impaired. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a quantitative impairment test. Management carried out its qualitative review on the last day of the third quarter in 2024 and 2023. Our qualitative review showed no indicators of impairment in segments carrying goodwill. As a result, the Company concluded its review and was not required to perform a quantitative review.

U.K. Defined Benefit Pension Plan

The Company operates a funded defined benefit pension plan in the U.K., and immaterial plans in the U.S. and France. The amounts recognized in our consolidated financial statements related to our defined-benefit pension and other post-retirement plans are determined from actuarial valuations. Inherent in these valuations are assumptions, including: (i) discount rates; (ii) inflation rates; (iii) pension increases; and (iv) life expectancy. These assumptions are updated annually and are disclosed in ITEM 8, Note 15 to the Notes to Consolidated Financial Statements. Differences in actual experience or changes in assumptions can have a material impact on the pension and other post-retirement obligations and future expense.

We recognize changes in the fair value of plan assets and net actuarial gains or losses for pension and other post-retirement benefits annually in the fourth quarter each year ("mark-to-market adjustment") and, if applicable, in any quarter in which an interim remeasurement is triggered. Net actuarial gains and losses occur when the actual experience differs from any of the various assumptions used to value our pension and other post-retirement plans or when assumptions change as they may each year. The primary factors contributing to actuarial gains and losses each year are (i) changes in the discount rate used to value pension and other post-retirement benefit obligations as of the measurement date and (ii) differences between the expected and the actual return on plan assets. This accounting method also results in the potential for volatile and difficult to forecast mark-to-market adjustments. The remaining components of pension expense, including service and interest costs and the expected return on plan assets, are recorded on a quarterly basis as ongoing pension expense.

Discount rate

The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. This yield produced a weighted-average discount rate for our U.K. plans of 5.40% in 2024, 4.50% in 2023 and 4.80% in 2022. The discount rate on our U.S. plans was n/a in 2024 and 2023, and 5.10% in 2022. There are no known or anticipated changes in our discount rate assumption that will impact our pension expense in 2025.

To indicate the sensitivity of results to this assumption, a 0.1% per annum increase in the discount rate for our U.K. plans would reduce the value of the liabilities and therefore increase the pension surplus by approximately $2.5 million and increase the projected 2025 income statement credit by approximately $0.1 million.

41

Inflation rate

In September 2019, the UK Statistics Authority announced plans to reform the RPI inflation index. On November 25, 2020, the government and UK Statistics Authority confirmed these plans to reform the RPI index to bring it into line with the CPIH index from 2030, with no compensation for the holders of index-linked gilts. Inflation measured by the CPIH is consistently significantly lower than that measured by RPI, and therefore, these plans imply a significant expected reduction in RPI inflation from 2030 onwards. As a result we have taken a stepped approach and used different inflation rates pre and post 2030.

To indicate the sensitivity of results to the CPI assumption, a 0.1% per annum decrease in all CPI-linked assumptions, (including pension increases) for our U.K. plan, would reduce the value of the liabilities and therefore increase the pension surplus at December 31, 2024 by approximately $1.3 million and increase the projected 2024 income statement credit by approximately $0.1 million.

Pension increases

The pension increase assumptions have been set with reference to the corresponding CPI inflation assumption and take account of the caps and floors applicable to the various components of pension indexation.

Life expectancy

The life expectancies of male and female members aged 65 on 31 December 2024 are assumed to be 20.1 and 22.7 years, respectively, with the life expectancies of male and female members aged 65 on 31 December 2044 assumed to be 21.3 and 24.1 years, respectively.

To indicate the sensitivity of results to the life expectancy assumption, a one year increase in assumed life expectancy on the U.K. plan could increase the value of the liabilities and therefore decrease the pension surplus at December 31, 2024 by approximately $6.3 million.

Expected rate of return

Our expected rate of return on plan assets for our U.K. plans was 5.80% in 2024, 4.80% in 2023 and 5.60% in 2022. The expected rate of return on our U.S. plans was n/a in 2024 and 2023, and 4.70% in 2022. The expected rate of return is designed to be a long-term assumption that may be subject to considerable year-to-year variance from actual returns. In developing the expected long-term rate of return, we considered our historical returns, with consideration given to forecast economic conditions, our asset allocations, input from external consultants and broader longer-term market indices.

See ITEM 8, Note 15 of the Notes to Consolidated Financial Statements for further information regarding pension and other post-retirement plans.

42

FY 2023 10-K MD&A

SEC filing source: 0001096056-24-000011.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2024-02-27. Report date: 2023-12-31.

Item 7.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Annual Report on Form 10-K contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Annual Report, as well as:

•general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

•worldwide economic and business conditions and conditions in the industries in which we operate;

•our ability to execute our strategic review, including our Graphic Arts business, to safeguard margins and reduce costs;

•post-pandemic impact of COVID-19 and future pandemics;

•fluctuations in the cost and / or availability of raw materials, labor and energy, as well as our ability to pass on cost increases to customers;

•currency fluctuations and other financial risks;

•our ability to protect our intellectual property;

•the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

•relationships with our customers and suppliers;

•increased competition from other companies in the industries in which we operate;

•changing technology;

•our ability to execute and integrate new acquisitions;

•claims for personal injury, death or property damage arising from the use of products produced by us;

•the occurrence of accidents or other interruptions to our production processes;

•changes in our business strategy or development plans, and our expected level of capital expenditure;

•our ability to attract and retain qualified personnel;

•restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

•climate change regulations and the potential impact on energy costs;

•regulatory, environmental, legislative and judicial developments; and

•our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," of this Annual Report on Form 10-K for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

30

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Luxfer is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Key trends and uncertainties regarding our existing business

Margin pressure resulting from supply chain challenges easing

We have recently experienced supply chain challenges, which resulted in higher cost of certain raw materials. In our supply chain, previously described challenges caused by the disruption in our U.S. domestic magnesium supply continued, and overall competitive cost pressures persisted. These issues have been particularly acute in our Graphic Arts segment, where the ability to pass through higher costs to our customers has proved to be constrained. In recent months however, the purchase price of Magnesium has been falling, which will result in lower input cost in 2024. We have implemented elements of our strategic review in Graphic Arts to reduce costs, including a headcount reduction program. We are also pursuing further actions to improve margins and maintain strong cash flow across the business.

In the majority of cases we are able to pass through inflationary costs to our customers, although we are still constrained by a small number of contracts, particularly in the Gas Cylinders segment, the longest running of which is not subject to renewal until mid-2024. However, our expectation is that the adverse impact of material availability / inflation, energy cost inflation and labor and transport constraints will lessen in 2024 and when costs fall we will look to share cost savings with customers through lower pricing. However the outlook remains highly uncertain with both the size and timing of future cost increases difficult to predict.

Operating objectives and trends

In 2024, we expect the following operating objectives and trends to impact our business:

•Addressing general macro uncertainty and building resilience into the outlook, especially in our General Industrial end-market;

•Execution of actions identified upon completion of the recently-announced expanded and accelerated strategic review, including the divestiture of Graphic Arts;

•Completion of long-term agreement renewals in Gas Cylinders enabling pass through of inflationary costs;

•Ongoing focus on cost control, new product launches and productivity improvements across the business;

•Execution of selected capital investment projects to support our strategy of profitable growth while maintaining our infrastructure;

•Continued emphasis on operating cash generation and maintaining strong working capital performance;

•Further improvements in ESG standing through focus on sustainability and on our values of teamworking and accountability; and

•Focus on recruiting, developing and maintaining talent, including our new leadership development programs, while driving a high-performance culture.

31

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations from continuing operations of Luxfer were as follows:

Years ended December 31,% / point change
In millions2023202220212023 v 20222022 v 2021
Net sales$405.0$423.4$374.1(4.3)%13.2%
Cost of sales(328.4)(328.4)(278.1)%18.1%
Gross profit76.695.096.0(19.4)%(1.0)%
% of net sales18.9%22.4%25.7%(3.5)(3.3)
Selling, general and administrative expenses(48.7)(43.1)(47.3)13.0%(8.9)%
% of net sales12.0%10.2%12.6%1.8(2.4)
Research and development(4.6)(4.9)(3.9)(6.1)%25.6%
% of net sales1.1%1.2%1.0%(0.1)0.2
Restructuring charges(6.4)(1.9)(6.2)236.8%(69.4)%
% of net sales1.6%0.4%1.7%1.2(1.3)
Impairment charges(12.7)n/an/a
% of net sales3.1%%%3.1
Acquisition and disposals costs(0.3)(1.5)(100.0)%(80.0)%
% of net sales%0.1%0.4%(0.1)(0.3)
Other income0.2n/a(100.0)%
% of net sales%%0.1%(0.1)
Other charges(1.1)n/a(100.0)%
% of net sales%%0.3%(0.3)
Operating income4.244.836.2(90.6)%23.8%
% of net sales1.0%10.6%9.7%(9.6)0.9
Net interest expense(6.3)(3.9)(3.1)61.5%25.8%
% of net sales1.6%0.9%0.8%0.70.1
Defined benefit pension (charge) / credit(7.6)0.12.3n/a(95.7)%
% of net sales(1.9)%%0.6%(1.9)(0.6)
(Loss) / income before income taxes(9.7)41.035.4n/a15.8%
% of net sales(2.4)%9.7%9.5%(12.1)0.2
Credit / (provision) for income taxes7.1(9.0)(5.4)n/a66.7%
Effective tax rate73.2%22.0%15.3%51.26.7
Net (loss) / income from continuing operations$(2.6)$32.0$30.0n/a6.7%
% of net sales(0.6)%7.6%8.0%(8.2)(0.4)

32

Net sales

Adjusting for foreign exchange headwinds of $0.3 million, consolidated net sales have decreased by 4.3% in 2023 from 2022. The adverse impact of volume and mix has accounted for a $43.1 million reduction in sales, while the passing through of material cost inflation, where not constrained by contract, has partially offset this decrease by $25.0 million.

While sales in our General Industrial and Transportation end markets have decreased by 23.9% and 10.2% respectively, our sales in our Defense, First Response and Healthcare end market has increased by 23.9%.

Overall sales have been negatively impacted by:

•Decreased demand for photo-engraving plates, particularly outside the North American market due to competitive pressure from increased raw material costs;

•Lower sales of SoluMag® in the Oil and Gas industry;

•Reduction in sales of magnesium powders for commercial use; and

•Lower demand for AF cylinders, coupled with industrial cylinders' sales being weaker in the year.

These decreases were partially offset by:

•Increased sales of our SCBA and medical cylinders;

•Increase in demand for zirconium products, particularly those used in pharmaceutical applications;

•Significant increase in sales of chemical response kits; and

•Strong demand for our new unitized ration product ("UGR-E") in quarter two.

Gross profit

The 3.5 percentage point decrease in gross profit as a percentage of sales in 2023 from 2022 was primarily the result of adverse sales mix and higher materials costs relative to price increases. These issues have been particularly acute in our Graphic Arts Division where the ability to pass through higher costs to our customers has proved to be constrained with the emergence of lower cost competition. However, cost recovery and margin has improved throughout the year in the Gas Cylinders Division as fixed-priced contracts continue to be renegotiated.

Selling, general and administrative expenses ("SG&A")

SG&A costs as a percentage of sales have increased by 1.8 percentage points in 2023 from 2022, largely due to the $5.9 million of legal costs expensed in the Elektron Division. These predominantly relate to the case described in Note 19 and are not expected to recur in 2024.

Research and development costs

Research and development costs as a percentage of sales declined marginally in 2023 when compared to 2022 although overall spend of $4.6 million continues to show our commitment to new product development.

Restructuring charges

The $6.4 million restructuring charges in 2023 includes:

•$3.0 million of asset impairments and $2.3 million asset relocation, restructuring and other costs in relation to the rationalization of our North American Gas Cylinders businesses to reduce our fixed cost base;

•An additional $0.4 million in relation to the closure of Luxfer Gas Cylinders France;

•$0.2 million of further redundancies within our Gas Cylinders division;

•$0.5 million of waste clean up costs and $0.2 million of asset impairments in the Elektron division in relation to the consolidation of production facilities in the Magnesium Powders operations; and

•$0.2 million credit in relation to the closure of our Elektron Division's Canadian facility.

33

Acquisition and disposals costs

There were no acquisition or disposals costs in 2023.

Impairment charges

The $12.7 million impairment charges incurred in 2023 arose from fully writing down property, plant and equipment and right of use assets from operating leases within our Graphic Arts division as a result of our annual impairment and strategic review.

Net interest expense

Net interest expense of $6.3 million in 2023 increased from $3.9 million in 2022 due to the continued combination of increased interest rates and higher drawings on the revolving credit facility.

Defined benefit pension credit

The defined benefit pension charge of $7.6 million in 2023 was predominantly the result of the sale of the U.S. pension plan liability to an insurer. In the first quarter of 2023, there was a $9.2 million charge in relation to the sale, which included $2.3 million cash and $6.9 million in relation to the derecognition of the U.S. pension liability and reallocation of accumulated actuarial losses from other comprehensive income. In the second quarter of 2023, we received a $0.2 million contribution refund, resulting in a net cash outflow of $2.1 million and a charge of $9.0 million in 2023 in relation to the settlement. An additional $0.3 million interest cost has been recognized in relation to the U.S. plan in the year.

This charge was partially offset by a $1.7 million credit on the U.K. plan as expected return on assets outweighed the interest cost and net actuarial loss.

Provision for income taxes

The 51.2 percentage point increase in the effective tax rate in 2023 from 2022 was primarily due to the impact of increase tax credits in relation to U.K. incentives and the U.K. rate change from 19% to 25%, partially offset by the jurisdictional mix of income.

2022 compared with 2021

For a discussion comparing our consolidated operating results for the year ended December 31, 2022, with the year ended December 31, 2021, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the U.S. Securities and Exchange Commission on March 01, 2023. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2023.

34

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following tables of non-GAAP summary financial data presents a reconciliation of net income from continuing operations and diluted earnings per ordinary share from continuing operations to adjusted net income from continuing operations, adjusted EBITA from continuing operations, adjusted income from continuing operations before income taxes, adjusted EBITDA from continuing operations, adjusted earnings per ordinary share from continuing operations, adjusted provision for income taxes and adjusted effective tax rate from continuing operations, for the periods presented, being the most comparable GAAP measures. Management believes that adjusted net income, adjusted earnings per share, adjusted EBITA and adjusted EBITDA are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income from continuing operations, adjusted earnings per share from continuing operations, adjusted EBITA from continuing operations and adjusted EBITDA from continuing operations in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability.

Years ended December 31,
In millions except per share data202320222021
Net (loss) / income from continuing operations(2.6)32.030.0
Accounting charges relating to acquisitions and disposals of businesses:
Amortization on acquired intangibles0.80.70.9
Acquisitions and disposals cost0.31.5
Defined benefit pension credit7.6(0.1)(2.3)
Restructuring charges6.41.96.2
Impairment charges12.7
Other charges1.1
Share-based compensation charges2.82.52.8
Tax impact of defined benefit pension settlement(4.9)
Other non-recurring tax items(1.9)
Income tax on adjusted items(6.4)0.1(2.1)
Adjusted net income from continuing operations16.437.436.2
Adjusted earnings per ordinary share from continuing operations
Diluted earnings per ordinary share(0.10)1.161.07
Impact of adjusted items0.700.200.22
Adjusted diluted earnings per ordinary share(1)0.611.361.29

(1) For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees.

Years ended December 31,
In millions except per share data202320222021
Adjusted net income from continuing operations16.437.436.2
Add back:
Tax impact of defined benefit pension settlement4.9
Other non-recurring tax items1.9
Income tax on adjusted items6.4(0.1)2.1
Income tax expense(7.1)9.05.4
Net finance costs6.33.93.1
Adjusted EBITA from continuing operations26.950.248.7
Depreciation11.912.914.7
Adjusted EBITDA from continuing operations38.863.163.4

35

Years ended December 31,
In millions202320222021
Adjusted net income from continuing operations$16.4$37.4$36.2
Add back:
Tax impact of defined benefit pension settlement4.9
Other non-recurring tax items1.9
Income tax on adjusted items6.4(0.1)2.1
Provision for income taxes(7.1)9.05.4
Adjusted income from continuing operations before income taxes$20.6$46.3$45.6
Adjusted provision for income taxes4.28.99.4
Adjusted effective tax rate from continuing operations20.4%19.2%20.6%

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our three reportable segments (Gas Cylinders, Elektron and Graphic Arts). The three segments comprise various product offerings that serve multiple end-markets.

During 2023, the Graphic Arts reporting segment has been disaggregated from the Elektron segment and is being reported separately as the Graphic Arts segment. The Elektron segment's results for 2022 and 2021 have been adjusted to strip out Graphic Arts' results.

Adjusted EBITDA, which is our segment income metric, represents net income from continuing operations adjusted for share-based compensation charges, restructuring charges, impairment charges, other charges, acquisitions and disposals costs, net interest expenses, defined benefits pension credit, provision for taxes and depreciation and amortization.. A reconciliation to net income can be found in ITEM 8, Note 17.

GAS CYLINDERS

The results of operations from the Gas Cylinders segment are for continuing operations only.

The net sales and adjusted EBITDA for Gas Cylinders were as follows:

Years ended December 31,% / point change
In millions2023202220212023 v 20222022 v 2021
Net sales$186.4$183.7$178.31.5%3.0%
Adjusted EBITDA16.712.822.730.5%(43.6)%
% of net sales9.0%7.0%12.7%2.0(5.7)

Net sales

The 1.5% increase in Gas Cylinders sales in 2023 from 2022 was primarily the result of:

•Higher sales of SCBA cylinders;

•Increased volume of our medical cylinders; and

•Price increases throughout the segment as contracts are renegotiated.

These increases have been partially offset by:

•Reduced sales of industrial and AF cylinders.

Net sales in Gas Cylinders continued to be impacted throughout the year by the fixed-price contracts in place across the segment, although we have been able to renegotiate some of our fixed-price contracts to offset inflation.

36

Adjusted EBITDA

The 2.0 percentage point increase in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2023 from 2022 is the result of the renegotiation of fixed price contracts, as price more than offset inflation during the year.

ELEKTRON

The net sales and adjusted EBITDA for Elektron were as follows:

Years ended December 31,% / point change
In millions2023202220212023 v 20222022 v 2021
Net sales$187.1$201.0$155.7(6.9)%29.1%
Adjusted EBITDA26.642.534.1(37.4)%24.6%
% of net sales14.2%21.1%21.9%(6.9)(0.8)

Net sales

The 6.9% decrease in Elektron sales in 2023 from 2022 was negatively impacted by adverse volume and mix, while price increase contributed an additional $9.6 million. Primary movements were:

•Lower sales of SoluMag® in the Oil and Gas industry; and

•Reduction in sales of magnesium powders for commercial use.

These decreases were partially offset by increased sales of chemical response kits and flameless ration heaters. There has also been continued increase in demand for zirconium products, particularly those used in pharmaceutical applications, as well as increases in our industrial end-market.

Adjusted EBITDA

The 6.9 percentage point decrease in adjusted EBITDA for Elektron as a percentage of net sales in 2023 from 2022 was primarily the result of adverse product mix across the segment and increased legal fees, coupled with $1.0 million FX headwind. Price increases throughout the year more than offset inflation.

GRAPHIC ARTS

The net sales and adjusted EBITDA for Graphic Arts were as follows:

Years ended December 31,% / point change
In millions2023202220212023 v 20222022 v 2021
Net sales$31.5$38.7$40.1(18.6)%(3.5)%
Adjusted EBITDA(4.5)7.86.6n/a18.2%
% of net sales(14.3)%20.2%16.5%n/a3.7

Net sales

The 18.6% decrease in Graphic Arts sales in 2023 from 2022 was a result of decreased demand for photo-engraving plates, particularly outside the North American market as competition has increased as a result of recent inflation, especially the high cost of magnesium.

Adjusted EBITDA

The loss in 2023 for Graphic Arts was a result of lower volumes coupled with the increased cost of magnesium filtering through. High fixed costs and the lowering of pricing to slow sales decline had a negative impact on margins.

37

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility ("RCF") and accompanying ancillary hedging facilities and the Loan Note due 2026. Our principal liquidity needs are:

•funding acquisitions;

•capital expenditure requirements;

•payment of shareholder dividends;

•servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the RCF;

•working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

•hedging facilities used to manage our foreign exchange and aluminum purchase price risks.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales. Also, our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

We have been in compliance with the covenants under the Loan Notes and the RCF throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2023.

In January 2023, the Company increased the capacity of its existing RCF to $125.0 million, an increase of $25.0 million. In June 2023, the Company repaid the $25.0 million loan note due in 2023.

Luxfer conducts all of its operations through its subsidiaries, joint ventures and affiliates. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

Cash Flows from Continuing Operations

Operating activities

Cash provided by operating activities was $26.2 million and $15.8 million in 2023 and 2022 respectively, which includes approximately $3.6 million and $10.0 million of cash spent on restructuring activities in those years. Cash was primarily related to the net loss / net income from operating activities, net of the following non-cash items: (i) depreciation and amortization; (ii) share-based compensation charges; (iii) pension adjustments (iv) impairment charges and (v) net changes to assets and liabilities. In 2022, the Company had increased its working capital balances, predominantly as a result of inventory build to try and reduce inflationary price rises, 2023 saw a corresponding reduction in those balances.

38

Investing activities

Net cash used for investing activities was $9.4 million in 2023, compared to $5.6 million in 2022. The following investing activities impacted our cash flow:

Capital expenditures

Capital expenditures in 2023 was $9.4 million compared to $8.3 million in 2022. We anticipate capital expenditures for 2024 to be between $11 million and $14 million as we increase investment in order to grow the business.

Proceeds from sale of property, plant and equipment

In May 2022, the Company sold a previously held-for-sale building in the Elektron segment for $3.7 million. Consideration was paid in full upon sale.

Settlements from sale of business

In October 2022, the Company agreed a final settlement of $1.0 million to the purchasers of the previously disposed aluminum gas cylinder business. The settlement was a reduction to the original consideration paid.

Financing activities

In 2023, net cash used for financing activities was $27.5 million, (2022: $2.0 million). We repaid $25.0 million of short term borrowings, partially offset by a $4.3 million increase in our bank overdraft. We made net drawdowns on our borrowing facilities of $10.2 million (2022: net drawdowns of $24.8 million) and dividend payments of $14.0 million (2022: $14.2 million), equating to $0.52 per ordinary share (2022: $0.515 per ordinary share). In 2023, the Company spent $2.7 million repurchasing approximately 200,000 shares, (2022: $11.1 million repurchasing approximately 700,000 shares).

Loan Note 2026

The Note Purchase Agreement contains customary covenants and events of default, in each case with customary and appropriate grace periods and thresholds. In addition, the Note Purchase Agreement requires us to maintain compliance with a minimum interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Note Purchase Agreement) to Net Finance Charges (as defined in the Note Purchase Agreement). We are required to maintain an interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Note Purchase Agreement) to Adjusted Acquisition EBITDA (as defined in the Note Purchase Agreement). We are required to maintain a leverage ratio of no more than 3.0:1. We have been in compliance with the covenants under the Note Purchase Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2023.

The Loan Note due 2026 and the Note Purchase Agreement are governed by the law of the State of New York.

The Loan Note due 2026 is denominated in U.S. dollars, which creates a natural partial offset between the dollar-denominated net assets and earnings of our U.S. operations and the dollar-denominated debt and related interest expense of the notes. We have included the Note Purchase Agreement and a form of the Loan Note due 2026 as exhibits to this Annual Report and refer you to the exhibits for more information on the Note Purchase Agreement and the Loan Note due 2026.

Senior Facilities Agreement

A new Senior Facilities Agreement was signed in October 2021, for more information see ITEM 8 Note 11.

Structure.At December 31, 2023 the Senior Facilities Agreement provided $125 million of committed debt facilities in the form of a multi-currency (GBP sterling, U.S. dollars or euros) RCF and an additional $25 million of uncommitted facilities through an accordion clause. The facilities mature in October 2026. As of December 31, 2023, we had drawn down $43.1 million under the Revolving Credit Facility (December 31, 2022: $31.9 million).

39

Availability.    The facility is used for loans and overdrafts. Amounts unutilized under the RCF (or, if the case, under the revolving portion of the accordion) are allocated to ancillary facilities available under the Senior Facilities Agreement in connection with overdraft facilities, bilateral loan facilities and letter of credit facilities. As of December 31, 2023, we had drawn down $2.2 million under the ancillary facilities (December 31, 2022: $1.8 million). We may use amounts drawn under the RCF for our general corporate purposes and certain capital expenditures, as well as for the financing of permitted acquisitions and reorganizations. As of December 31, 2023, $81.9 million (net of $43.1 million drawn down) was available under the RCF. The last month in which we may draw funds from the RCF is September 2026.

The Company also had a separate (uncommitted) bonding facility for bank guarantees; denominated in GBP sterling totaling £0.5 million ($0.6 million) and £0.1 million ($0.2 million) was utilized at December 31, 2023.

Interest rates and fees.    Borrowings under the facility bear an interest rate equal to an applicable margin plus either EURIBOR, in the case of amounts drawn in euros, or SONIA (Sterling Overnight Index Average), in the case of amounts drawn in GBP sterling or U.S. dollars.

The tables below sets out the range of ratios and the related margin percentage currently in effect.

LeverageMargin
(% per annum)
Greater than 2.5:12.75
Less than or equal to 2.5:1, but greater than 2.0:12.50
Less than or equal to 2.0:1, but greater than 1.5:12.25
Less than or equal to 1.5:1, but greater than 1.0:12.00
Less than or equal to 1.0:11.75

As of December 31, 2023, we had drawn down $43.1 million under the RCF (December 31, 2022: $31.9 million). A commitment fee is levied each quarter against any unutilized element of the RCF, excluding overdraft or ancillary facilities.

In the event of a sale of all or substantially all of our business and / or assets, or if any person or group of persons acting in concert gains direct or indirect control (as defined in the Senior Facilities Agreement) of Luxfer Holdings PLC, we will be required to immediately repay all outstanding amounts under the RCF (and, if the case, the accordion) and the ancillary facilities under the Senior Facilities Agreement.

In addition, the Senior Facilities Agreement requires us to maintain compliance with an interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Senior Facilities Agreement) to Net Finance Charges (as defined in the Senior Facilities Agreement). We are required to maintain a minimum interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Senior Facilities Agreement) to the Relevant Period Adjusted Acquisition EBITDA (as defined in the Senior Facilities Agreement). We are required to maintain a leverage ratio of no more than 3.0:1.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2023.

The Senior Facilities Agreement is governed by English law. For more information see ITEM 8, Note 11.

Dividends

We paid dividends in 2023 of $14.0 million (2022: $14.2 million), or $0.52 (2022: $0.515) per ordinary share.

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and the International Accounting Standards Board, which differ in some respects from U.S. GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

40

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

Payments Due by Period
In millionsTotalLess than 1 year1 – 3 years3 – 5 yearsAfter 5 years
Contractual cash obligations
Loan Notes due 202625.025.0
Revolving Credit Facility43.143.1
Bank overdraft4.64.6
Obligations under operating leases26.05.49.22.78.7
Capital commitments2.32.3
Interest payments11.14.26.9
Total contractual cash obligations$112.1$16.5$84.2$2.7$8.7

2022 compared with 2021

For a discussion comparing our net cash activities (operating, investing and financing) for the year ended December 31, 2022, with the year ended December 31, 2021, refer to Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation - Discussion and Analysis - Consolidated Operating Results in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the U.S. Securities and Exchange Commission on March 01, 2023. This section is incorporated by reference into this Annual Report on Form 10-K for the year ended December 31, 2023.

Off-balance sheet measures

At December 31, 2023, we had no off-balance sheet arrangements other than the three bonding facilities as described above.

COMMITMENTS AND CONTINGENCIES

Capital commitments

At December 31, 2023, the Company had capital expenditure commitments of $2.3 million (2022: $1.4 million and 2021: $1.5 million) for the purchase of new plant and equipment.

Committed banking facilities

The Company refinanced in October 2021, see Note 11 for details of the refinance.

At December 31, 2023 the Company had committed banking facilities of $125.0 million with an additional $25.0 million of uncommitted facilities through an accordion provision. Of these committed facilities, $43.1 million was drawn at December 31, 2023. The banking facilities expire in October 2026.

At December 31, 2022, the Company had committed banking facilities of $100.0 million with an additional $50.0 million of uncommitted facilities through an accordion provision. Of the committed facilities, $31.9 million was drawn at December 31, 2022.

41

Contingencies

In November 2018, an alleged explosion occurred at a third-party waste disposal and treatment site in Grand View, Idaho, reportedly causing property damage, personal injury, and one fatality. The Company had contracted with a service company for removal and disposal of certain waste resulting from the magnesium powder manufacturing operations at the Reade facility in Manchester, New Jersey. The Company believes this service company, in turn, contracted with the third-party disposal company, at whose facility the explosion occurred, for treatment and disposal of the waste. In November 2020, we were named as a defendant in three lawsuits in relation to the incident – one by the third-party disposal company, one by the estate of the decedent, and one by an injured employee of the third-party disposal company. The three lawsuits were administratively consolidated and, to date, two lawsuits remain ongoing. The Company believes that we are not liable for the incident, have asserted such, and, in conjunction with our insurers, continue to fully defend the Company against these lawsuits. Therefore, we do not currently expect any eventual outcome in these matters to have a material impact on the Company's financial position or results of operations.

In December 2023, it was established that any potential liability arising from the lawsuits and reasonable defense costs related thereto are covered by insurance. Negotiations as to recovery of historic defense costs are ongoing, and therefore the Company has not recognized any asset with respect to said recovery as of December 31, 2023.

NEW ACCOUNTING STANDARDS

See ITEM 8, Note 1 of the notes to the Consolidated Financial Statements, included in this Form 10-K, for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

CRITICAL ACCOUNTING ESTIMATES

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Our significant accounting policies are more fully described in ITEM 8, Note 1 of the Notes to Consolidated Financial Statements. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, terms of existing contracts, our observance of trends in the industry and information available from other outside sources, as appropriate. We consider an accounting estimate to be critical if:

•it requires us to make assumptions about matters that were uncertain at the time we were making the estimate; and

•changes in the estimate or different estimates that we could have selected would have had a material impact on our financial condition or results of operations.

Our critical accounting estimates include the following:

Impairment of goodwill and identifiable intangible assets

Goodwill

Goodwill represents the excess of the cost of acquired businesses over the net of the fair value of identifiable net assets purchased and liabilities assumed.

Goodwill is tested at least annually for impairment and is tested for impairment more frequently if events or changes in circumstances indicate that the asset might be impaired. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a quantitative impairment test. Management carried out its qualitative review on the last day of the third quarter in 2023 and 2022. Our qualitative review showed no indicators of impairment in segments carrying goodwill. As a result, the Company concluded its review and was not required to perform a quantitative review.

42

Pension and other post-retirement plans

We sponsor U.S. and non-U.S. defined-benefit pension and other post-retirement plans, although we sold our significant U.S. defined pension plan in 2023. The amounts recognized in our consolidated financial statements related to our defined-benefit pension and other post-retirement plans are determined from actuarial valuations. Inherent in these valuations are assumptions, including: (i) discount rates; (ii) inflation rates; (iii) pension increases; and (iv) life expectancy. These assumptions are updated annually and are disclosed in ITEM 8, Note 14 to the Notes to Consolidated Financial Statements. Differences in actual experience or changes in assumptions can have a material impact on the pension and other post-retirement obligations and future expense.

We recognize changes in the fair value of plan assets and net actuarial gains or losses for pension and other post-retirement benefits annually in the fourth quarter each year ("mark-to-market adjustment") and, if applicable, in any quarter in which an interim remeasurement is triggered. Net actuarial gains and losses occur when the actual experience differs from any of the various assumptions used to value our pension and other post-retirement plans or when assumptions change as they may each year. The primary factors contributing to actuarial gains and losses each year are (i) changes in the discount rate used to value pension and other post-retirement benefit obligations as of the measurement date and (ii) differences between the expected and the actual return on plan assets. This accounting method also results in the potential for volatile and difficult to forecast mark-to-market adjustments. The remaining components of pension expense, including service and interest costs and the expected return on plan assets, are recorded on a quarterly basis as ongoing pension expense.

Discount rate

The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. This yield produced a weighted-average discount rate for our U.K. plans of 4.50% in 2023, 4.80% in 2022 and 1.90% in 2021. The discount rate on our U.S. plans was 5.10% in 2022 and 2.70% in 2021. There are no known or anticipated changes in our discount rate assumption that will impact our pension expense in 2024.

To indicate the sensitivity of results to this assumption, a 0.1% per annum increase in the discount rate for our U.K. plans would reduce the value of the liabilities and therefore increase the pension surplus by approximately $2.0 million and increase the projected 2023 income statement credit by approximately $0.2 million.

Inflation rate

In September 2019, the UK Statistics Authority announced plans to reform the RPI inflation index. On November 25, 2020, the government and UK Statistics Authority confirmed these plans to reform the RPI index to bring it into line with the CPIH index from 2030, with no compensation for the holders of index-linked gilts. Inflation measured by the CPIH is consistently significantly lower than that measured by RPI, and therefore, these plans imply a significant expected reduction in RPI inflation from 2030 onwards. As a result we have taken a stepped approach and used different inflation rates pre and post 2030.

To indicate the sensitivity of results to the CPI assumption, a 0.1% per annum decrease in all CPI-linked assumptions, (including pension increases) for our U.K. plan, would reduce the value of the liabilities and therefore increase the pension surplus at December 31, 2022 by approximately $1.0 million and increase the projected 2024 income statement credit by approximately $0.1 million.

Pension increases

The pension increase assumptions have been set with reference to the corresponding CPI inflation assumption and take account of the caps and floors applicable to the various components of pension indexation.

Life expectancy

The life expectancies of male and female members aged 65 on 31 December 2023 are assumed to be 21.2 and 23.1 years, respectively, with the life expectancies of male and female members aged 65 on 31 December 2043 assumed to be 22.5 and 24.6 years, respectively.

To indicate the sensitivity of results to the life expectancy assumption, a one year increase in assumed life expectancy on the U.K. plan could increase the value of the liabilities and therefore decrease the pension surplus at December 31, 2023 by approximately $8.0 million.

43

Expected rate of return

Our expected rate of return on plan assets for our U.K. plans was 4.80% in 2023, 5.60% in 2022 and 3.30% in 2021. The expected rate of return on our U.S. plans was 4.70% in 2022 and 2.50% in 2021. The expected rate of return is designed to be a long-term assumption that may be subject to considerable year-to-year variance from actual returns. In developing the expected long-term rate of return, we considered our historical returns, with consideration given to forecast economic conditions, our asset allocations, input from external consultants and broader longer-term market indices.

See ITEM 8, Note 14 of the Notes to Consolidated Financial Statements for further information regarding pension and other post-retirement plans.

Loss contingencies

Accruals are recorded for various contingencies, including legal proceedings, self-insurance and other claims that arise in the normal course of business. The accruals are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarial determined estimates. Additionally, we record receivables from third party insurers when recovery has been determined to be probable.

Our critical judgment revolves around the recognition of litigation and environmental liabilities in relation to the closure of our French site. We have recognized a loss contingency of $3.0 million, for which we have engaged with external experts to assist with the valuation of these liabilities.

44

FY 2022 10-K MD&A

SEC filing source: 0001096056-23-000009.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2023-03-01. Report date: 2022-12-31.

Item 7.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Annual Report on Form 10-K contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Annual Report, as well as:

•general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

•worldwide economic and business conditions and conditions in the industries in which we operate;

•post-pandemic impact of COVID-19 and future pandemics;

•fluctuations in the cost and / or availability of raw materials, labor and energy, as well as the ability to pass on cost increases to customers;

•currency fluctuations and other financial risks;

•our ability to protect our intellectual property;

•the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

•relationships with our customers and suppliers;

•increased competition from other companies in the industries in which we operate;

•changing technology;

•our ability to execute and integrate new acquisitions;

•claims for personal injury, death or property damage arising from the use of products produced by us;

•the occurrence of accidents or other interruptions to our production processes;

•changes in our business strategy or development plans, and our expected level of capital expenditure;

•our ability to attract and retain qualified personnel;

•restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

•climate change regulations and the potential impact on energy costs;

•regulatory, environmental, legislative and judicial developments; and

•our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," of this Annual Report on Form 10-K for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

27

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean and energy-efficient world. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Key trends and uncertainties regarding our existing business

Update on ongoing challenging global macro environment and related impact on supply chain disruption

Demand from most end-markets we serve has continued to improve following the adverse impact of COVID-19 on volumes, notably in 2020. This sharp recovery in demand across the global macro environment has resulted in supply chain challenges characterized by significant increases in material cost inflation on key inputs (including magnesium, aluminum and carbon fiber), labor availability issues and energy and transport cost increases. Additionally, during 2022, we were faced with two critical suppliers of magnesium and zirconium respectively declaring force majeure, of which the former remains in place. The continuing conflict in Ukraine which has resulted in punitive sanctions against the Russian Federation has further exacerbated the availability and price of certain raw materials and energy supplies. In response to the supply chain disruption, we have been successful in securing alternative sources of supply for key material inputs affected by force majeure. Furthermore, in the majority of cases, we are able to pass through inflation to our customers. Currently, our expectation is that the impact of material availability / inflation and energy cost inflation and labor and transport constraints will continue into 2023; that we will be able to source sufficient material to meet demand and that in the majority of cases we expect to be able to pass on cost increases. However the outlook remains highly uncertain with both the size and timing of future cost increases difficult to predict.

Impact of conflict in Ukraine

The Russian invasion of Ukraine and ongoing military conflict which commenced on February 24, 2022, has resulted in massive displacement of the Ukrainian population and huge disruption to its economy. Wide ranging sanctions have been imposed on the Russian Federation by the international community, targeting individuals, banks, businesses, funds transfers and imports and exports and are expected to have a significant adverse impact on Russia's economy as well as on international businesses active in the region. The impact on Luxfer is not expected to be significant as we have no direct operations in the region, and our sales to Russia and Ukraine combined typically represent less than one percent of total revenue by destination. Furthermore, neither country is a critical supplier of our raw material needs, and while Russia is a major global exporter of magnesium, we are able to source the metal from various alternative locations, including China, Israel, Turkey and the United States.

Operating objectives and trends

In 2023, we expect the following operating objectives and trends to impact our business:

•Continuing high activity on revenue growth initiatives with particular focus on increasing volumes;

•Actions to ensure continuity of supply of critical materials and services while safeguarding margins;

•Execution of productivity improvements and increases in selling prices to mitigate and pass through current cost pressure;

•Further improvements in ESG standing through investment in new projects;

•Focus on recruiting, developing and maintaining talent, through our new leadership development programs, while driving a high-performance culture; and

•Continued emphasis on operating cash generation and maintaining strong working capital performance.

28

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations from continuing operations of Luxfer were as follows:

Years ended December 31,% / point change
In millions2022202120202022 v 20212021 v 2020
Net sales$423.4$374.1$324.813.2%15.2%
Cost of sales(328.4)(278.1)(243.9)18.1%14.0%
Gross profit95.096.080.9(1.0)%18.7%
% of net sales22.4%25.7%24.9%(3.3)0.8
Selling, general and administrative expenses(43.1)(47.3)(39.8)(8.9)%18.8%
% of net sales10.2%12.6%12.3%(2.4)0.3
Research and development(4.9)(3.9)(3.3)25.6%18.2%
% of net sales1.2%1.0%1.0%0.2
Restructuring charges(1.9)(6.2)(8.9)(69.4)%(30.3)%
% of net sales0.4%1.7%2.7%(1.3)(1.0)
Acquisition and disposals costs(0.3)(1.5)(80.0)%n/a
% of net sales0.1%0.4%%(0.3)0.4
Other income0.2(100.0)%n/a
% of net sales%0.1%%(0.1)n/a
Other charges(1.1)(0.4)(100.0)%175.0%
% of net sales%0.3%0.1%(0.3)0.2
Operating income44.836.228.523.8%27.0%
% of net sales10.6%9.7%8.8%0.90.9
Net interest expense(3.9)(3.1)(5.0)25.8%(38.0)%
% of net sales0.9%0.8%1.5%0.1(0.7)
Defined benefit pension credit0.12.34.3(95.7)%(46.5)%
% of net sales%0.6%1.3%(0.6)(0.7)
Income before income taxes and equity in net income of affiliates41.035.427.815.8%27.3%
% of net sales9.7%9.5%8.6%0.20.9
Provision for income taxes(9.0)(5.4)(6.9)66.7%(21.7)%
Effective tax rate22.0%15.3%24.8%6.7(9.5)
Income before equity in net income of affiliates32.030.020.96.7%43.5%
% of net sales7.6%8.0%6.4%(0.4)1.6
Equity in loss of unconsolidated affiliates (net of tax)(0.1)%(100.0)%
% of net sales%%%
Net income from continuing operations$32.0$30.0$20.86.7%44.2%
% of net sales7.6%8.0%6.4%(0.4)1.6

29

Net sales

Adjusting for foreign exchange headwinds of $13.9 million, consolidated net sales have increased by 16.9% in 2022 from 2021. The passing through of material cost inflation, where not constrained by contract, accounted for approximately 75.0% of this increase. Furthermore, there was benefit in the year from:

•Increased sales of magnesium powders used in commercial and military applications;

•Higher demand for composite cylinders used in aerospace and medical applications, although constrained by historical contractual prices;

•Increased sales of magnesium alloys, especially those used in the aerospace market;

•Higher demand for our zirconium products, particularly in industrial applications; and

•An additional contribution to net sales in Luxfer Gas Cylinders of $7.1 million due to the acquisition of Structural Composites Industries LLP ("SCI") at the end of the first quarter 2021, which primarily impacted sales of cylinders used in aerospace and alternative fuels applications.

These increases were partially offset by:

•Unfavorable foreign exchange variances as highlighted above;

•Softening sales of flameless ration heaters ("FRH") due to lower levels of troop deployment and of Chemical detection kits due to supply chain constraints, and

•Reduced sales of CNG alternative fuel cylinders.

The 15.2% increase in consolidated net sales across most major product groups in 2021 from 2020 was primarily due to the acquisition of SCI, as well as the recovery in volumes adversely impacted by COVID-19 in the prior year. The most significant factors were:

•An additional contribution of $24.9 million due to the acquisition of SCI;

•Increased sales of SCBA cylinders used by first responders and of cylinders used for gas calibration and other industrial applications;

•Increased sales in Luxfer MEL Technologies of zirconium automotive catalysis products;

•Increased sales of military powders used in countermeasure flares;

•Increased sales of Luxfer Graphic Arts magnesium photo-engraving plates; and

•Favorable foreign exchange variances of $10.3 million or 3.2%.

These increases were partially offset by decreased sales of heater meals and chemical response kits in our Luxfer Magtech business.

Gross profit

The 3.3 percentage point decrease in gross profit as a percentage of sales in 2022 from 2021 was primarily the result of increased material and labor costs and other supply chain investments to overcome disruption, not fully covered by price increases, particularly in the Gas Cylinders Division.

The 0.8 percentage point increase in gross profit as a percentage of sales in 2021 from 2020 was primarily the result of production efficiency linked to increased volumes as we recovered from the prior year impact of COVID-19. This was partially offset by the impact of material cost inflation not fully covered by price increases primarily in the fourth quarter.

30

Selling, general and administrative expenses ("SG&A")

SG&A costs as a percentage of sales have decreased by 2.4 percentage points in 2022 from 2021, largely due to the impact of price increases on revenue, as well as cost reduction programs effected in the prior year. We also benefited from foreign currency translation of $2.3 million.

SG&A costs as a percentage of sales increased marginally by 0.3 percentage points in 2021 from 2020.

Research and development costs

Research and development costs as a percentage of sales has increased by 0.2 percentage points in 2022 when compared to 2021, with actual expenditure increasing by 25.6%, reflecting increased investment in new products and future growth capability.

Research and development costs as a percentage of sales were flat in 2021 when compared to 2020, with actual expenditure increasing by 18.2% as activity levels picked up as we recovered from the COVID-19 economic downturn.

Restructuring charges

The $1.9 million restructuring charges in 2022 includes:

•A further $1.7 million in relation to the closure of Luxfer Gas Cylinders France; and

•$0.2 million relating to one-time employee termination benefits in the Elektron division in relation to the consolidation of production facilities in the Magnesium Powders operations.

The $6.2 million restructuring charges in 2021 includes:

•A further $5.0 million in relation to the closure of Luxfer Gas Cylinders France;

•$0.9 million of one-time employee termination costs in the Elektron division, largely in relation to the divestiture of our small Luxfer Magtech production facility in Ontario, Canada; and

•$0.3 million of miscellaneous restructuring project costs in the Gas Cylinders division.

Acquisition and disposals costs

Net costs of $0.3 million and $1.5 million in 2022 and 2021 respectively, primarily relate to the 2021 acquisition of SCI.

Other charges

The $1.1 million other charges incurred in 2021 relates to the settlement of a class action lawsuit in the Gas Cylinders segment from an alleged historic violation of the California Labor Code, concerning a Human Resources administration matter.

Net interest expense

Net interest expense of $3.9 million in 2022 increased from $3.1 million in 2021 due to a combination of increased interest rates and higher drawings.

Net interest expense of $3.1 million in 2021 decreased from $5.0 million in 2020 largely due to the $25 million early repayment in December 2020 of the Loan Notes due in 2021.

Defined benefit pension credit

The defined benefit pension credit of $0.1 million in 2022, includes a credit on the U.K. plan of $3.0 million, partially offset by the recognition of $2.9 million of unamortized losses on the U.S. plan as a result of the settlement triggered by the lump sum exercise in 2022, ahead of the buyout of the U.S. pension plan which we expect to be completed in early 2023.

The defined benefit pension credit of $2.3 million has decreased by $2.0 million in 2021 from 2020. This was primarily due to the combined effect on the U.K. plan of lower projected asset returns and a higher post-2030 inflation projection in the U.K., partially offset by a fall in the discount rate.

31

Provision for income taxes

The 6.7 percentage point increase in the effective tax rate in 2022 from 2021 was primarily due to the impact in the prior year of the U.K. tax rate change enacted (from 19% to 25%) which increased the valuation of the U.K. related net deferred tax asset (largely related to the U.K. defined benefit pension plan).

The 9.5 percentage point decrease in the effective tax rate in 2021 from 2020 was primarily due to the impact of the above mentioned change in the U.K. tax rate. In addition, a deferred tax credit of $2.6 million has been recognized in the income statement in respect of future tax relief available as a result of a special one-off pension contribution made to the U.K. plan in December 2021.

32

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following table of non-GAAP summary financial data presents a reconciliation of net income from continuing operations to adjusted net income for the periods presented, being the most comparable GAAP measure. Management believes that adjusted net income, adjusted earnings per share, adjusted EBITA and adjusted EBITDA are key performance indicators ("KPIs") used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income and adjusted earnings per share in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability.

Years ended December 31,
In millions except per share data202220212020
Net income from continuing operations32.030.020.8
Accounting charges relating to acquisitions and disposals of businesses:
Amortization on acquired intangibles0.70.90.7
Acquisitions and disposals cost0.31.5
Defined benefit pension credit(0.1)(2.3)(4.3)
Restructuring charges1.96.28.9
Other charges1.10.4
Share-based compensation charges2.52.82.8
Other non-recurring tax items(1.9)
Income tax on adjusted items0.1(2.1)(0.4)
Adjusted net income from continuing operations37.436.228.9
Adjusted earnings per ordinary share from continuing operations
Diluted earnings per ordinary share1.161.070.74
Impact of adjusted items0.200.220.29
Adjusted diluted earnings per ordinary share(1)1.361.291.03

(1) For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees.

Years ended December 31,
In millions except per share data202220212020
Adjusted net income from continuing operations37.436.228.9
Add back:
Other non-recurring tax items1.9
Income tax on adjusted items(0.1)2.10.4
Income tax expense9.05.46.9
Net finance costs3.93.15.0
Adjusted EBITA from continuing operations50.248.741.2
Loss on disposal of property, plant and equipment0.1
Depreciation12.914.712.6
Adjusted EBITDA from continuing operations63.163.453.9

33

The following table presents a reconciliation for the adjusted effective tax rate, which management believes is a KPI used by the investment community and that such presentation will enhance an investor's understanding of the Company's operational results.

Years ended December 31,
In millions202220212020
Adjusted net income from continuing operations$37.4$36.2$28.9
Add back:
Other non-recurring tax items1.9
Income tax on adjusted items(0.1)2.10.4
Provision for income taxes9.05.46.9
Adjusted income from continuing operations before income taxes$46.3$45.6$36.2
Adjusted provision for income taxes8.99.47.3
Adjusted effective tax rate from continuing operations19.2%20.6%20.2%

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our two reportable segments (Gas Cylinders and Elektron). Both segments comprise various product offerings that serve multiple end-markets.

Adjusted EBITDA, which is our segment income metric, represents operating income adjusted for restructuring charges, other charges, acquisitions and disposals cost, depreciation and amortization, and share-based compensation charges. A reconciliation to net income and taxes can be found in ITEM 8, Note 17.

GAS CYLINDERS

The results of operations from the Gas Cylinders segment are for continuing operations only.

The net sales and adjusted EBITDA for Gas Cylinders were as follows:

Years ended December 31,% / point change
In millions2022202120202022 v 20212021 v 2020
Net sales$183.7$178.3$141.93.0%25.7%
Adjusted EBITDA12.822.721.3(43.6)%6.6%
% of net sales7.0%12.7%15.0%(5.7)(2.3)

Net sales

The 3.0% increase in Gas Cylinders sales in 2022 from 2021 was primarily the result of increased demand for composite cylinders used in aerospace, partially offset by $7.8 million of foreign exchange headwind and a reduction in CNG alternative fuel and SCBA cylinder sales. The segment has benefited from $7.1 million of sales due to the acquisition of SCI at the end of the first quarter in 2021, which has positively impacted sales of cylinders in aerospace and alternative fuels.

Net sales in Gas Cylinders have been impacted throughout the year by the fixed-price contracts in place across the segment.

The 25.7% increase in Gas Cylinders sales in 2021 from 2020 was primarily the result of the recovery of our markets following COVID-19 related disruption in the prior year, as well as the acquisition of SCI which generated $24.9 million of additional revenues. Revenues increased across all significant product lines except for medical oxygen cylinders, sales of which had held up relatively well in the prior year.

34

Adjusted EBITDA

The 5.7 percentage point decrease in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2022 from 2021 is a result of the segment being impacted by timing of contractually constrained cost pass-through. Cost reduction effort activities more than offset adverse foreign exchange impact in the year.

The 2.3 percentage point decrease in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2021 from 2020 was primarily the result of losses suffered by the newly acquired SCI business from the end of the first quarter, as well as material cost inflation in excess of price increases primarily in the fourth quarter. This was partially offset by productivity improvements as volumes recovered from the Covid-19 affected prior year.

ELEKTRON

The net sales and adjusted EBITDA for Elektron were as follows:

Years ended December 31,% / point change
In millions2022202120202022 v 20212021 v 2020
Net sales$239.7$195.8$182.922.4%7.1%
Adjusted EBITDA50.340.732.623.6%24.8%
% of net sales21.0%20.8%17.8%0.23.0

Net sales

The 22.4% increase in Elektron sales in 2022 from 2021 was heavily impacted by the passing through of material cost-inflation. Furthermore, there was benefit in the year from:

•Increased sales of magnesium powders used in commercial and military applications;

•Improved sales of magnesium alloys, especially those used in the aerospace market; and

•Higher demand for our zirconium products, particularly in industrial applications.

These increases were partially offset by a decrease in sales of FRHs and chemical kits supplied by Luxfer Magtech. Net sales were also adversely impacted by $6.1 million of foreign exchange.

The 7.1% increase in Elektron sales in 2021 from 2020 was primarily the result of the recovery from COVID-19 related disruption affecting the prior year, especially:

•Increased sales of zirconium-based industrial catalysts;

•Increased sales of magnesium photo-engraving plates;

•Increased sales of military powders used in countermeasure flares; and

•Increased sales of wrought magnesium alloys, especially those used in our transportation end markets.

This was partially offset by decreased revenues from Luxfer Magtech chemical detection kits and from heater meals.

Adjusted EBITDA

The 0.2 percentage point increase in adjusted EBITDA for Elektron as a percentage of net sales in 2022 from 2021 was primarily the result of the segment's ability to pass on the inflationary cost increases, as well as the benefit of positive foreign exchange variances.

The 3.0 percentage point increase in adjusted EBITDA for Elektron as a percentage of net sales in 2021 from 2020 was primarily the result of productivity improvements as volumes recovered from the Covid-19 affected prior year, as well as favorable product sales mix.

35

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility ("RCF") and accompanying ancillary hedging facilities and the Loan Notes due 2023 and 2026. Our principal liquidity needs are:

•funding acquisitions;

•capital expenditure requirements;

•payment of shareholder dividends;

•servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the RCF;

•working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

•hedging facilities used to manage our foreign exchange and aluminum purchase price risks.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales. Also, our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

We have been in compliance with the covenants under the Loan Notes and the RCF throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2022.

In October 2021, the Company completed a refinancing of its existing RCF, extending its tenure to October 2026, while providing increased flexibility to incur additional indebtedness outside of this agreement if required and reducing the covenant burden. In January 2023, the Company has increased the capacity of its existing RCF to $125.0 million, an increase of $25.0 million.

Luxfer conducts all of its operations through its subsidiaries, joint ventures and affiliates. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

36

Cash Flows from Continuing Operations

Operating activities

Cash provided by operating activities was $15.8 million and $26.0 million in 2022 and 2021 respectively, which includes approximately $10.0 million and $4.0 million of cash spent on restructuring activities in those years. It was primarily related to net income from operating activities, net of the following non-cash items: (i) depreciation and amortization; (ii) share-based compensation charges; (iii) pension adjustments and (iv) net changes to assets and liabilities. In 2022, the Company has increased its working capital balances, predominantly as a result of inventory build to try and reduce inflationary price rises. In 2021, the Company also made an additional, special one-off deficit reduction payment in the U.K. for $12.7 million.

Investing activities

Net cash used for investing activities was $5.6 million in 2022, compared to net cash used for investing activities of $5.0 million in 2021. The following investing activities impacted our cash flow:

Capital expenditures

Capital expenditures in 2022 was $8.3 million compared to $9.1 million in 2021. 2021 included additional spend as we delayed some projects in the prior year in response to COVID-19. We anticipate capital expenditures for 2023 to be around $15 million as we increase investment in order to grow the business.

Proceeds from sale of property, plant and equipment

In May 2022, the Company sold a previously held-for-sale building in the Elektron segment for $3.7 million. Consideration was paid in full upon sale.

Proceeds from sale of business

In March 2021, the Company sold its U.S. aluminum gas cylinder business for net cash proceeds of $20.2 million. In September 2021, the Company sold its Superform U.K. business for net consideration of $4.0 million, of which $3.0 million was received in 2021 and $1.0 million deferred until 2022. The deferred consideration, while still due to the Company, the payment has not yet been received so has been fully impaired in 2022.

In July 2020, the Company sold its 51% investment in Luxfer Uttam India Private Limited for net cash proceeds of $1.5 million. In September 2021, the Company received deferred consideration of $0.3 million for this sale.

Settlements from sale of business

In October 2022, the Company agreed a final settlement of $1.0 million to the purchasers of the previously disposed aluminum gas cylinder business. The settlement was a reduction to the original consideration paid.

Acquisitions, net of cash acquired

In March 2021, the Company completed the acquisition of the SCI business of Worthington Industries, Inc., based in Pomona, California, for $19.3 million cash consideration.

Financing activities

In 2022, net cash used for financing activities was $2.0 million, (2021: $16.1 million). We made net drawdowns on our borrowing facilities of $24.8 million (2021: net drawdowns of $6.4 million) and dividend payments of $14.2 million (2021: $13.6 million), equating to $0.515 per ordinary share (2021: $0.50 per ordinary share). In 2022, the Company spent $11.1 million repurchasing approximately 700,000 shares, (2021: $6.4 million repurchasing approximately 300,000 shares).

Loan Notes 2023 and 2026

The Note Purchase Agreement contains customary covenants and events of default, in each case with customary and appropriate grace periods and thresholds. In addition, the Note Purchase Agreement requires us to maintain compliance with a minimum interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Note Purchase Agreement) to Net Finance Charges (as defined in the Note Purchase Agreement). We are required to maintain an interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Note Purchase Agreement) to Adjusted Acquisition EBITDA (as defined in the Note Purchase Agreement). We are required to maintain a leverage ratio of no more than 3.0:1. We have been in compliance with the covenants under the Note Purchase Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2022.

37

The Loan Notes due 2023 and 2026 and the Note Purchase Agreement are governed by the law of the State of New York.

The Loan Notes due 2023 and 2026 are denominated in U.S. dollars, which creates a natural partial offset between the dollar-denominated net assets and earnings of our U.S. operations and the dollar-denominated debt and related interest expense of the notes. We have included the Note Purchase Agreement and a form of the Loan Notes due 2023 and 2026 as exhibits to this Annual Report and refer you to the exhibits for more information on the Note Purchase Agreement and the Loan Notes due 2023 and 2026.

Senior Facilities Agreement

A new Senior Facilities Agreement was signed in October 2021, for more information see ITEM 8 Note 11.

Structure.    At December 31, 2022 the Senior Facilities Agreement provided $100 million of committed debt facilities in the form of a multi-currency (GBP sterling, U.S. dollars or euros) RCF and an additional $50 million of uncommitted facilities through an accordion clause. In January 2023, we increased the RCF to $125 million and a subsequent reduction in the uncommitted facility to $25 million. The facilities mature in October 2026. As of December 31, 2022, we had drawn down $31.9 million under the Revolving Credit Facility (December 31, 2021: $10.8 million).

Availability.    The facility is used for loans and overdrafts. Amounts unutilized under the RCF (or, if the case, under the revolving portion of the accordion) are allocated to ancillary facilities available under the Senior Facilities Agreement in connection with overdraft facilities, bilateral loan facilities and letter of credit facilities. As of December 31, 2022, we had drawn down $1.8 million under the ancillary facilities (December 31, 2021: $2.2 million). We may use amounts drawn under the RCF for our general corporate purposes and certain capital expenditures, as well as for the financing of permitted acquisitions and reorganizations. As of December 31, 2022, $68.1 million (net of $31.9 million drawn down) was available under the RCF. The last month in which we may draw funds from the RCF is September 2026.

The Company also had a separate (uncommitted) bonding facility for bank guarantees; denominated in GBP sterling totaling £0.5 million ($0.6 million) and £0.1 million ($0.2 million) was utilized at December 31, 2022.

Interest rates and fees.    Borrowings under the facility bear an interest rate equal to an applicable margin plus either EURIBOR, in the case of amounts drawn in euros, or SONIA (Sterling Overnight Index Average), in the case of amounts drawn in GBP sterling or U.S. dollars.

The tables below sets out the range of ratios and the related margin percentage currently in effect.

LeverageMargin
(% per annum)
Greater than 2.5:12.75
Less than or equal to 2.5:1, but greater than 2.0:12.50
Less than or equal to 2.0:1, but greater than 1.5:12.25
Less than or equal to 1.5:1, but greater than 1.0:12.00
Less than or equal to 1.0:11.75

As of December 31, 2022, we had drawn down $31.9 million under the RCF (December 31, 2021: $10.8 million). A commitment fee is levied each quarter against any unutilized element of the RCF, excluding overdraft or ancillary facilities.

In the event of a sale of all or substantially all of our business and / or assets, or if any person or group of persons acting in concert gains direct or indirect control (as defined in the Senior Facilities Agreement) of Luxfer Holdings PLC, we will be required to immediately repay all outstanding amounts under the RCF (and, if the case, the accordion) and the ancillary facilities under the Senior Facilities Agreement.

In addition, the Senior Facilities Agreement requires us to maintain compliance with an interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Senior Facilities Agreement) to Net Finance Charges (as defined in the Senior Facilities Agreement). We are required to maintain a minimum interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Senior Facilities Agreement) to the Relevant Period Adjusted Acquisition EBITDA (as defined in the Senior Facilities Agreement). We are required to maintain a leverage ratio of no more than 3.0:1.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2022.

38

The Senior Facilities Agreement is governed by English law. For more information see ITEM 8, Note 11.

Dividends

We paid dividends in 2022 of $14.2 million (2021: $13.6 million), or $0.515 (2021: $0.50) per ordinary share.

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and the International Accounting Standards Board, which differ in some respects from U.S. GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

Payments Due by Period
In millionsTotalLess than 1 year1 – 3 years3 – 5 yearsAfter 5 years
Contractual cash obligations
Loan Notes due 202325.025.0
Loan Notes due 202625.025.0
Revolving Credit Facility31.931.9
Obligations under operating leases29.95.110.15.39.4
Capital commitments1.41.4
Interest payments13.24.06.62.6
Total contractual cash obligations$126.4$35.5$16.7$64.8$9.4

Off-balance sheet measures

At December 31, 2022, we had no off-balance sheet arrangements other than the three bonding facilities as described above.

COMMITMENTS AND CONTINGENCIES

Capital commitments

At December 31, 2022, the Company had capital expenditure commitments of $1.4 million (2021: $1.5 million and 2020: $1.1 million) for the purchase of new plant and equipment.

Committed banking facilities

The Company refinanced in October 2021, see Note 11 for details of the refinance.

At December 31, 2022 the Company had committed banking facilities of $100.0 million with an additional $50.0 million of uncommitted facilities through an accordion provision. Of these committed facilities, $31.9 million was drawn at December 31, 2022.

At December 31, 2021, the Company had committed banking facilities of $100.0 million with an additional $50.0 million of uncommitted facilities through an accordion provision. Of the committed facilities, $10.8 million was drawn at December 31, 2021.

39

Contingencies

In November 2018, an alleged explosion occurred at a third-party waste disposal and treatment site in Grand View, Idaho, reportedly causing property damage, personal injury, and one fatality. We contracted with a service company for removal and disposal of certain waste resulting from the magnesium powder manufacturing operations at the Reade facility in Manchester, New Jersey. We believe this service company, in turn, contracted with the third-party disposal company, at whose facility the explosion occurred, for treatment and disposal of the waste. In November 2020, we were named as a defendant in three lawsuits in relation to the incident – one by the third-party disposal company, one by the estate of the decedent, and one by an injured employee of the third-party disposal company. We believe that we are not liable for the incident, have asserted such, and continue to fully defend the Company against these lawsuits. Therefore, we do not currently expect any eventual outcome in these matters to have a material impact on the Company's financial position or results of operations.

NEW ACCOUNTING STANDARDS

See ITEM 8, Note 1 of the notes to the Consolidated Financial Statements, included in this Form 10-K, for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

CRITICAL ACCOUNTING ESTIMATES

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Our significant accounting policies are more fully described in ITEM 8, Note 1 of the Notes to Consolidated Financial Statements. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, terms of existing contracts, our observance of trends in the industry and information available from other outside sources, as appropriate. We consider an accounting estimate to be critical if:

•it requires us to make assumptions about matters that were uncertain at the time we were making the estimate; and

•changes in the estimate or different estimates that we could have selected would have had a material impact on our financial condition or results of operations.

Our critical accounting estimates include the following:

Impairment of goodwill and other identifiable intangible assets

Goodwill

Goodwill represents the excess of the cost of acquired businesses over the net of the fair value of identifiable tangible net assets and identifiable intangible assets purchased and liabilities assumed.

Goodwill is tested at least annually for impairment and is tested for impairment more frequently if events or changes in circumstances indicate that the asset might be impaired. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a quantitative impairment test. Management carried out its qualitative review on the last day of the third quarter of 2022 and 2021, which showed no indicators of impairment. As a result, the Company concluded its review and was not required to perform a quantitative review.

Identifiable intangible assets

Our primary identifiable intangible assets include: (i) customer relationships and technology; and (ii) traded related assets. All our identifiable intangible assets have finite lives and are amortized over that period. Identifiable intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. No such events occurred during the year ended December 31, 2022.

40

Pension and other post-retirement plans

We sponsor U.S. and non-U.S. defined-benefit pension and other post-retirement plans. The amounts recognized in our consolidated financial statements related to our defined-benefit pension and other post-retirement plans are determined from actuarial valuations. Inherent in these valuations are assumptions, including: (i) discount rates; (ii) inflation rates; (iii) pension increases; and (iv) life expectancy. These assumptions are updated annually and are disclosed in ITEM 8, Note 14 to the Notes to Consolidated Financial Statements. Differences in actual experience or changes in assumptions can have a material impact on the pension and other post-retirement obligations and future expense.

We recognize changes in the fair value of plan assets and net actuarial gains or losses for pension and other post-retirement benefits annually in the fourth quarter each year ("mark-to-market adjustment") and, if applicable, in any quarter in which an interim remeasurement is triggered. Net actuarial gains and losses occur when the actual experience differs from any of the various assumptions used to value our pension and other post-retirement plans or when assumptions change as they may each year. The primary factors contributing to actuarial gains and losses each year are (i) changes in the discount rate used to value pension and other post-retirement benefit obligations as of the measurement date and (ii) differences between the expected and the actual return on plan assets. This accounting method also results in the potential for volatile and difficult to forecast mark-to-market adjustments. The remaining components of pension expense, including service and interest costs and the expected return on plan assets, are recorded on a quarterly basis as ongoing pension expense.

Discount rate

The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. This yield produced a weighted-average discount rate for our U.K. plans of 4.80% in 2022, 1.90% in 2021 and 1.40% in 2020. The discount rate on our U.S. plans was 5.10% in 2022, 2.70% in 2021 and 2.30% in 2020. There are no known or anticipated changes in our discount rate assumption that will impact our pension expense in 2023.

To indicate the sensitivity of results to this assumption, a 0.1% per annum increase in the discount rate for our U.K. plans would reduce the value of the liabilities and therefore increase the pension surplus by approximately $2.4 million and increase the projected 2023 income statement credit by approximately $0.1 million.

Inflation rate

In September 2019, the UK Statistics Authority announced plans to reform the RPI inflation index. On November 25, 2020, the government and UK Statistics Authority confirmed these plans to reform the RPI index to bring it into line with the CPIH index from 2030, with no compensation for the holders of index-linked gilts. Inflation measured by the CPIH is consistently significantly lower than that measured by RPI, and therefore, these plans imply a significant expected reduction in RPI inflation from 2030 onwards. As a result we have taken a stepped approach and used different inflation rates pre and post 2030.

To indicate the sensitivity of results to the CPI assumption, a 0.1% per annum decrease in all CPI-linked assumptions, (including pension increases) for our U.K. plan, would reduce the value of the liabilities and therefore increase the pension surplus at December 31, 2022 by approximately $2.4 million and increase the projected 2023 income statement credit by approximately $0.1 million.

Pension increases

The pension increase assumptions have been set with reference to the corresponding CPI inflation assumption and take account of the caps and floors applicable to the various components of pension indexation.

Life expectancy

The life expectancies of male and female members aged 65 on 31 December 2022 are assumed to be 21.2 and 23.0 years, respectively, with the life expectancies of male and female members aged 65 on 31 December 2042 assumed to be 22.5 and 24.5 years, respectively.

To indicate the sensitivity of results to the life expectancy assumption, a one year increase in assumed life expectancy on the U.K. plan could increase the value of the liabilities and therefore decrease the pension surplus at December 31, 2022 by approximately $7.2 million.

41

Expected rate of return

Our expected rate of return on plan assets for our U.K. plans was 5.60% in 2022, 3.30% in 2021 and 3.00% in 2020. The expected rate of return on our U.S. plans was 4.70% in 2022, 2.50% in 2021 and 5.00% in 2020. The expected rate of return is designed to be a long-term assumption that may be subject to considerable year-to-year variance from actual returns. In developing the expected long-term rate of return, we considered our historical returns, with consideration given to forecast economic conditions, our asset allocations, input from external consultants and broader longer-term market indices.

See ITEM 8, Note 14 of the Notes to Consolidated Financial Statements for further information regarding pension and other post-retirement plans.

Loss contingencies

Accruals are recorded for various contingencies, including legal proceedings, self-insurance and other claims that arise in the normal course of business. The accruals are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarial determined estimates. Additionally, we record receivables from third party insurers when recovery has been determined to be probable.

Our critical judgment revolves around the recognition of litigation and environmental liabilities in relation to the closure of our French site. We have recognized a loss contingency of $3.3 million, for which we have engaged with external experts to assist with the valuation of these liabilities.

42

FY 2021 10-K MD&A

SEC filing source: 0001096056-22-000015.

Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high. Filing date: 2022-02-24. Report date: 2021-12-31.

Item 7.        Management's Discussion and Analysis of Financial Condition and Results of Operations

Information regarding forward-looking statements

This Annual Report on Form 10-K contains certain statements, statistics and projections that are, or may be, forward-looking. These forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that could cause our actual results of operations, financial condition, liquidity, performance, prospects, opportunities, achievements or industry results, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or suggested by, these forward-looking statements. The accuracy and completeness of all such statements, including, without limitation, statements regarding our future financial position, strategy, plans and objectives for the management of future operations, is not warranted or guaranteed. These statements typically contain words such as "believes," "intends," "expects," "anticipates," "estimates," "may," "will," "should" and words of similar import. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Although we believe that the expectations reflected in such statements are reasonable, no assurance can be given that such expectations will prove to be correct. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements. These factors include, but are not limited to, factors identified in "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," or elsewhere in this Annual Report, as well as:

•general economic conditions, or conditions affecting demand for the services offered by us in the markets in which we operate, both domestically and internationally, being less favorable than expected;

•worldwide economic and business conditions and conditions in the industries in which we operate;

•ongoing impact of COVID-19 and future pandemics;

•fluctuations in the cost of raw materials and utilities;

•availability of essential inputs, including but not limited to, raw materials, transport, energy and labor;

•currency fluctuations and other financial risks;

•our ability to protect our intellectual property;

•the amount of indebtedness we have incurred and may incur, and the obligations to service such indebtedness and to comply with the covenants contained therein;

•relationships with our customers and suppliers;

•increased competition from other companies in the industries in which we operate;

•changing technology;

•our ability to execute and integrate new acquisitions;

•claims for personal injury, death or property damage arising from the use of products produced by us;

•the occurrence of accidents or other interruptions to our production processes;

•changes in our business strategy or development plans, and our expected level of capital expenditure;

•our ability to attract and retain qualified personnel;

•restrictions on the ability of Luxfer Holdings PLC to receive dividends or loans from certain of its subsidiaries;

•regulatory, environmental, legislative and judicial developments; and

•our intention to pay dividends.

Please read the sections "Business," "Risk factors," and "Management's Discussion and Analysis of Financial Condition and Results of Operations," of this Annual Report on Form 10-K for a more complete discussion of the factors that could affect our performance and the industries in which we operate, as well as those discussed in other documents we file or furnish with the SEC.

27

About Luxfer

Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering. Luxfer focuses on value creation by using its broad array of technical know-how and proprietary technologies. Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.

Key trends and uncertainties regarding our existing business

Update on impact of COVID-19 on operations

Demand from most end-markets we serve has improved throughout 2021 following the adverse impact of COVID-19 on prior year volumes. Current year fourth quarter like-for-like sales returned to positive growth versus the pre-pandemic 2019 level for the first time, but full year 2021 sales remained around 7% lower than 2019 given weakness in the first half of 2021. In addition, COVID-19 related supply chain disruption constrained our ability to fully convert robust demand into sales. Sharp recovery in demand combined with supply chain challenges has resulted in some adverse business impacts, including increased material cost inflation on key inputs (including magnesium, aluminum and carbon fiber), labor availability issues and energy and transport cost increases. Currently, our expectation is that the impact of material and energy cost inflation and labor and transport constraints will continue into 2022, although it is our intention to pass through inflation to our customers.

Luxfer’s top priority during this global pandemic has been the health and well-being of our employees, customers, shareholders, and the communities in which we operate. The Company continues to monitor the COVID-19 situation closely, including subsequent constraints on supply, while simultaneously executing business continuity plans. These business continuity plans include, but are not limited to: (i) retooling operations to maintain social distance and maximize employee safety; (ii) increasing resources to manage supply constraints and recruit employees in order to satisfy demand; (iii) expanding flexible work arrangements and policies, where practical, to maximize employee safety; and (iv) providing regular updates to our shareholders, employees, customers, and suppliers in a transparent and timely manner.

Operating objectives and trends

In 2022, we expect the following operating objectives and trends to impact our business:

•Organic growth initiatives with particular focus on revenue from new products;

•Actions to ensure continuity of supply of critical materials and services while safeguarding margins;

•Proactive response on health and well-being of employees post pandemic, including continuous improvement on safety;

•Targeted improvements in ESG standing through investment in new projects;

•Continued focus on recruiting and developing talent and driving a high-performance culture; and

•Continued focus on operating cash generation with lower restructuring activity and maintaining strong working capital performance.

28

CONSOLIDATED RESULTS OF OPERATIONS

The consolidated results of operations from continuing operations of Luxfer were as follows:

Years ended December 31,% / point change
In millions2021202020192021 v 20202020 v 2019
Net sales$374.1$324.8$373.415.2%(13.0)%
Cost of sales(278.1)(243.9)(269.7)14.0%(9.6)%
Gross profit96.080.9103.718.7%(22.0)%
% of net sales25.7%24.9%27.8%0.8(2.9)
Selling, general and administrative expenses(47.3)(39.8)(49.7)18.8%(19.9)%
% of net sales12.6%12.3%13.3%0.3(1.0)
Research and development(3.9)(3.3)(5.7)18.2%(42.1)%
% of net sales1.0%1.0%1.5%(0.5)
Restructuring charges(6.2)(8.9)(25.9)(30.3)%(65.6)%
% of net sales1.7%2.7%6.9%(1.0)(4.2)
Impairment credit0.2n/a(100.0)%
% of net sales%%(0.1)%0.1
Acquisition and disposals costs(1.5)(1.4)n/a(100.0)%
% of net sales0.4%%0.4%0.4(0.4)
Other income0.2n/an/a
% of net sales0.1%%%n/an/a
Other charges(1.1)(0.4)(2.5)175.0%(84.0)%
% of net sales0.3%0.1%0.7%0.2(0.6)
Operating income36.228.518.727.0%52.4%
% of net sales9.7%8.8%5.0%0.93.8
Net interest expense(3.1)(5.0)(4.4)(38.0)%13.6%
% of net sales0.8%1.5%1.2%(0.7)0.3
Defined benefit pension credit2.34.31.3(46.5)%230.8%
% of net sales0.6%1.3%0.3%(0.7)1.0
Income before income taxes and equity in net income of affiliates35.427.815.627.3%78.2%
% of net sales9.5%8.6%4.2%0.94.4
Provision for income taxes(5.4)(6.9)(7.6)(21.7)%(9.2)%
Effective tax rate15.3%24.8%48.7%(9.5)(23.9)
Income before equity in net income of affiliates30.020.98.043.5%161.3%
% of net sales8.0%6.4%2.1%1.64.3
Equity in (loss) / income of unconsolidated affiliates (net of tax)(0.1)0.7(100.0)%(114.3)%
% of net sales%%0.2%(0.2)
Net income from continuing operations$30.0$20.8$8.744.2%139.1%
% of net sales8.0%6.4%2.3%1.64.1

29

Net sales

The 15.2% increase in consolidated net sales across most major product groups in 2021 from 2020 was primarily due to the acquisition of Structural Composite Industries LLP ("SCI"), as well as the recovery in volumes adversely impacted by COVID-19 in the prior year. The most significant factors were:

•An additional contribution to net sales in Luxfer Gas Cylinders of $24.9 million due to the acquisition of SCI at the end of the first quarter, which primarily impacted sales of cylinders used in aerospace and alternative fuels applications;

•Increased sales of SCBA cylinders used by first responders and of cylinders used for gas calibration and other industrial applications;

•Increased sales in Luxfer MEL Technologies of zirconium automotive catalysis products;

•Increased sales of military powders used in countermeasure flares;

•Increased sales of Luxfer Graphic Arts magnesium photoengraving plates; and

•Favorable foreign exchange variances of $10.3 million or 3.2%.

These increases were partially offset by decreased sales of heater meals and chemical response kits in our Luxfer Magtech business.

The 13.0% decrease in consolidated net sales in 2020 from 2019 was heavily influenced by the global economic downturn resulting from the COVID-19 pandemic across all end-markets, with the adverse impact most pronounced across the industrial and transportation end-markets, including:

•Lower sales of photoengraving plates;

•Lower sales of zirconium-based chemical products used in industrial catalysis;

•Lower sales of SCBA cylinders used by first responders; and

•$7.6 million revenue decline as a result of the divestiture of Elektron's magnesium Czech recycling business in 2019.

These decreases were partially offset by:

•Continued growth of alternative fuel (AF) systems despite COVID-19 headwinds affecting transportation end-markets; and

•Increased revenues from Luxfer Magtech chemical kit products.

Gross profit

The 0.8 percentage point increase in gross profit as a percentage of sales in 2021 from 2020 was primarily the result of production efficiency linked to increased volumes as we recovered from the prior year impact of COVID-19. This was partially offset by the impact of material cost inflation not fully covered by price increases primarily in the fourth quarter.

The 2.9 percentage point decrease in gross profit as a percentage of sales in 2020 from 2019 was primarily the result of adverse sales mix and inefficiency from the impact of COVID-19.

These adverse factors were partially offset by the impact of productivity improvements in Luxfer Gas Cylinders Europe, following the closure of the French operation in 2019 and transfer of production to the U.K. and U.S.A.

30

Selling, general and administrative expenses ("SG&A")

SG&A costs as a percentage of sales have increased marginally by 0.3 percentage points in 2021 from 2020.

SG&A costs as a percentage of sales decreased by 1.0 percentage points in 2020 from 2019. The $9.9 million or 19.9%, decline in costs was primarily the result of continued cost savings derived from our transformation plan, as well as specific cost reduction actions taken in response to the COVID-19 pandemic.

Research and development costs

Research and development costs as a percentage of sales were flat in 2021 when compared to 2020, with actual expenditure increasing by 18.2% as activity levels picked up as we recovered from the COVID-19 economic downturn.

Research and development costs as a percentage of sales reduced by 0.5% in 2020 from 2019, largely as a result of COVID-19 caused project delays.

Restructuring charges

The $6.2 million restructuring charges in 2021 includes:

•A further $5.0 million in relation to the closure of Luxfer Gas Cylinders France;

•$0.9 million of one-time employee termination costs in the Elektron division, largely in relation to the divestiture of our small Luxfer Magtech production facility in Ontario, Canada; and

•$0.3 million of miscellaneous restructuring project costs in the Gas Cylinders division.

The $8.9 million restructuring charges in 2020 were the result of:

•A further $7.5 million in relation to the closure of Luxfer Gas Cylinders France; and

•$1.4 million in one-time severance costs as a result of actions taken in response to the COVID-19 pandemic.

Acquisition and disposals costs

Acquisition and disposals costs of $1.5 million in 2021 primarily relate to the acquisition of SCI.

Acquisition and disposals costs which were net nil in 2020 related to $0.4 million costs incurred in relation to merger and acquisition ("M&A") exploration activities offset by deferred consideration adjustments and profit on previously written-down inventory. In July 2020, we sold our 51% investment in Luxfer Uttam India Private Limited to the joint venture ("JV") partner. Allowing for legal costs, we generated a profit on disposal of less than $0.1 million.

Other charges

The $1.1 million other charges incurred in 2021 relates to the settlement of a class action lawsuit in the Gas Cylinders segment from an alleged historic violation of the California Labor Code, concerning a Human Resources administration matter.

The $0.4 million other charges incurred in 2020, is the result of further costs incurred in relation to the remediation of the legacy environmental issue at our Elektron Manchester, UK site,

Net interest expense

Net interest expense of $3.1 million in 2021 decreased from $5.0 million in 2020 largely due to the $25 million early repayment in December 2020 of the Loan Notes due in 2021.

Net interest expense of $5.0 million in 2020 increased from $4.4 million in 2019 largely as a result of an additional finance charge following the $25 million voluntary early repayment of 3.67% Loan notes due in 2021, at the end of the fourth quarter.

31

Defined benefit pension credit

The defined benefit pension credit of $2.3 million has decreased by $2.0 million in 2021 from 2020. This was primarily due to the combined effect on the U.K. plan of lower projected asset returns and a higher post-2030 inflation projection in the U.K., partially offset by a fall in the discount rate.

The $3.0 million increase in defined benefit pension credit in 2020 from 2019 was primarily due to the combined effect on the U.K. plan of a reduction in the discount rate and lower inflation, partially offset by lower projected asset returns.

Provision for income taxes

The 9.5 percentage point decrease in the effective tax rate in 2021 from 2020 was primarily due to the impact of the U.K. tax rate change enacted in the year (from 19% to 25%) which increased the valuation of the U.K. related net deferred tax asset (largely related to the U.K. defined benefit pension plan) as reported in the second quarter. In addition, a deferred tax credit of $2.6 million has been recognized in the income statement in respect of future tax relief available as a result of a special one-off pension contribution made to the U.K. plan in December 2021. The adjusted effective tax rate of 20.6% was marginally higher than the prior year rate of 20.2%, largely due to increased profits in higher tax jurisdictions, primarily the U.S.

The 23.9 percentage point increase in the effective tax rate in 2020 from 2019 was primarily due to significantly lower non-deductible expenses of a non-recurring nature in the current year.

32

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES TO GAAP MEASURES

The following table of non-GAAP summary financial data presents a reconciliation of net income from continuing operations to adjusted net income for the periods presented, being the most comparable GAAP measure. Management believes that adjusted net income, adjusted earnings per share, adjusted EBITA and adjusted EBITDA are key performance indicators (KPIs) used by the investment community and that such presentation will enhance an investor’s understanding of the Company's operational results. In addition, Luxfer's CEO and other senior management use these KPIs, among others, to evaluate business performance. However, investors should not consider adjusted net income and adjusted earnings per share in isolation as an alternative to net income and earnings per share when evaluating Luxfer's operating performance or measuring Luxfer's profitability.

Years ended December 31,
In millions except per share data202120202019
Net income from continuing operations30.020.88.7
Accounting charges relating to acquisitions and disposals of businesses:
Unwind of discount on deferred consideration0.2
Amortization on acquired intangibles0.90.71.2
Acquisitions and disposals cost1.51.4
Defined benefit pension credit(2.3)(4.3)(1.3)
Restructuring charges6.28.925.9
Impairment credit(0.2)
Other charges1.10.42.5
Share-based compensation charges2.82.84.5
Other non-recurring tax items(1.9)
Income tax on adjusted items(2.1)(0.4)(2.0)
Adjusted net income from continuing operations36.228.940.9
Adjusted earnings per ordinary share from continuing operations
Diluted earnings per ordinary share1.070.740.31
Impact of adjusted items0.220.291.16
Adjusted diluted earnings per ordinary share(1)1.291.031.47

(1) For the purpose of calculating diluted earnings per share, the weighted average number of ordinary shares outstanding during the financial year has been adjusted for the dilutive effects of all potential ordinary shares and share options granted to employees.

Years ended December 31,
In millions except per share data202120202019
Adjusted net income from continuing operations36.228.940.9
Add back:
Other non-recurring tax items1.9
Income tax on adjusted items2.10.42.0
Income tax expense5.46.97.6
Net finance costs3.15.04.4
Adjusted EBITA from continuing operations48.741.254.9
Loss on disposal of PPE0.10.2
Depreciation14.712.612.0
Adjusted EBITDA from continuing operations63.453.967.1

33

The following table presents a reconciliation for the adjusted effective tax rate, which management believes is a KPI used by the investment community and that such presentation will enhance an investor's understanding of the Company's operational results.

Years ended December 31,
In millions202120202019
Adjusted net income from continuing activities$36.2$28.9$40.9
Add back:
Other non-recurring tax items1.9
Income tax on adjusted items2.10.42.0
Provision for income taxes5.46.97.6
Adjusted income from continuing activities before income taxes$45.6$36.2$50.5
Adjusted provision for income taxes9.47.39.6
Adjusted effective tax rate from continuing activities20.6%20.2%19.0%

SEGMENT RESULTS OF OPERATIONS

The summary that follows provides a discussion of the results of operations of each of our two reportable segments (Gas Cylinders and Elektron). Both segments comprise various product offerings that serve multiple end-markets.

Adjusted EBITDA, which is our segment income metric, represents operating income adjusted for restructuring charges, impairment credit, other charges, acquisition and disposals cost, depreciation and amortization,; share based compensation charges, and unwind of discount on deferred consideration. A reconciliation to net income and taxes can be found in ITEM 8, Note 17.

GAS CYLINDERS

The results of operations from the Gas Cylinders segment are for continuing activities only.

The net sales and adjusted EBITDA for Gas Cylinders were as follows:

Years ended December 31,% / point change
In millions2021202020192021 v 20202020 v 2019
Net sales$178.3$141.9$153.525.7%(7.6)%
Adjusted EBITDA22.721.322.36.6%(4.5)%
% of net sales12.7%15.0%14.5%(2.3)0.5

Net sales

The 25.7% increase in Gas Cylinders sales in 2021 from 2020 was primarily the result of the recovery of our markets following COVID-19 related disruption in the prior year, as well as the acquisition of SCI at the end of the first quarter of the current year, which generated $24.9 million of additional revenues. Revenues increased across all significant product lines except for medical oxygen cylinders, sales of which had held up relatively well in the prior year.

The 7.6% decrease in Gas Cylinders sales in 2020 from 2019 was primarily the result of COVID-19 related disruption marked by temporary customer shutdowns, especially reduced sales of SCBA composite cylinders used by first responders. This was partially offset by continued growth in alternative fuel cylinder sales.

34

Adjusted EBITDA

The 2.3 percentage point decrease in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2021 from 2020 was primarily the result of losses suffered by the newly acquired SCI business from the end of the first quarter, as well as material cost inflation in excess of price increases primarily in the fourth quarter. This was partially offset by productivity improvements as volumes recovered from the Covid-19 affected prior year.

The 0.5 percentage point increase in adjusted EBITDA for Gas Cylinders as a percentage of net sales in 2020 from 2019 was primarily the result of productivity improvements and cost savings following the integration of the Luxfer Gas Cylinders France operation into other sites. This was partially offset by adverse sales mix.

ELEKTRON

The net sales and adjusted EBITDA for Elektron were as follows:

Years ended December 31,% / point change
In millions2021202020192021 v 20202020 v 2019
Net sales$195.8$182.9$219.97.1%(16.8)%
Adjusted EBITDA40.732.644.824.8%(27.2)%
% of net sales20.8%17.8%20.4%3.0(2.6)

Net sales

The 7.1% increase in Elektron sales in 2021 from 2020 was primarily the result of the recovery from COVID-19 related disruption affecting the prior year, especially:

•Increased sales of zirconium-based industrial catalysts;

•Increased sales of magnesium photo-engraving plates;

•Increased sales of military powders used in countermeasure flares; and

•Increased sales of wrought magnesium alloys, especially those used in our transportation end markets.

This was partially offset by decreased revenues from Luxfer Magtech chemical detection kits and from heater meals.

The 16.8% decrease in Elektron sales in 2020 from 2019 was primarily the result of COVID-19 related disruption especially to the industrial and transportation end-markets, including:

•Decreased sales of zirconium-based industrial catalysts;

•Lower sales of photo-engraving plates and military powders used in countermeasure flares;

•Lower sales of magnesium aerospace alloys; and

•$7.6 million revenue decline as a result of the divestiture of Elektron's magnesium Czech recycling business in 2019.

This was partially offset by increased revenues from Luxfer Magtech chemical detection kits.

Adjusted EBITDA

The 3.0 percentage point increase in adjusted EBITDA for Elektron as a percentage of net sales in 2021 from 2020 was primarily the result of productivity improvements as volumes recovered from the Covid-19 affected prior year, as well as favorable product sales mix.

The 2.6 percentage point decrease in adjusted EBITDA for Elektron as a percentage of net sales in 2020 from 2019 was primarily the result of the impact of Covid-19 related reduction in volumes more than offsetting associated cost saving measures. This was further impacted by adverse product sales mix.

35

LIQUIDITY AND CAPITAL RESOURCES

Our liquidity requirements arise primarily from obligations under our indebtedness, capital expenditures, acquisitions, the funding of working capital and the funding of hedging facilities to manage foreign exchange and commodity purchase price risks. We meet these requirements primarily through cash flows from operating activities, cash deposits and borrowings under the Revolving Credit Facility and accompanying ancillary hedging facilities and the Loan Notes due 2023 and 2026. Our principal liquidity needs are:

•funding acquisitions;

•capital expenditure requirements;

•payment of shareholder dividends;

•servicing interest on the Loan Notes, which is payable at each quarter end, in addition to interest and / or commitment fees on the Senior Facilities Agreement;

•working capital requirements, particularly in the short term as we aim to achieve organic sales growth; and

•hedging facilities used to manage our foreign exchange and aluminum purchase price risks.

We believe that, in the long term, cash generated from our operations will be adequate to meet our anticipated requirements for working capital, capital expenditures and interest payments on our indebtedness. In the short term, we believe we have sufficient credit facilities to cover any variation in our cash flow generation. However, any major repayments of indebtedness will be dependent on our ability to raise alternative financing or to realize substantial returns from operational sales. Also, our ability to expand operations through sales development and capital expenditures could be constrained by the availability of liquidity, which, in turn, could impact the profitability of our operations.

We have been in compliance with the covenants under the Loan Notes and the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2021.

In October 2021, the Company completed a refinancing of its existing Revolving Credit Facility, extending its tenure to 2026, while providing increased flexibility to incur additional indebtedness outside of this agreement if required and reducing the covenant burden.

Luxfer conducts all of its operations through its subsidiaries, joint ventures and affiliates. Accordingly, Luxfer's main cash source is dividends from its subsidiaries. The ability of each subsidiary to make distributions depends on the funds that a subsidiary receives from its operations in excess of the funds necessary for its operations, obligations or other business plans. We have not historically experienced any material impediment to these distributions, and we do not expect any local legal or regulatory regimes to have any impact on our ability to meet our liquidity requirements in the future. In addition, since our subsidiaries are wholly-owned, our claims will generally rank junior to all other obligations of the subsidiaries. If our operating subsidiaries are unable to make distributions, our growth may slow, unless we are able to obtain additional debt or equity financing. In the event of a subsidiary's liquidation, there may not be assets sufficient for us to recoup our investment in the subsidiary.

Our ability to maintain or increase the generation of cash from our operations in the future will depend significantly on the competitiveness of and demand for our products, including our success in launching new products. Achieving such success is a key objective of our business strategy. Due to commercial, competitive and external economic factors, however, we cannot guarantee that we will generate sufficient cash flows from operations or that future working capital will be available in an amount sufficient to enable us to service our indebtedness or make necessary capital expenditures.

36

Cash Flows from Continuing Operations

Operating activities

Cash provided by operating activities was $26.0 million in 2021, which includes approximately $4.0 million of cash spent on restructuring activities. It was primarily related to net income from operating activities, net of the following non-cash items: (i) depreciation and amortization; (ii) share based compensation charges; (iii) pension adjustments and (iv) net changes to assets and liabilities. The Company also made an additional, special one-off deficit reduction payment in the U.K. for $12.7 million.

Cash provided by operating activities was $49.3 million in 2020, which includes approximately $7.0 million of cash spent on restructuring activities. It was primarily related to net income from operating activities, net of the following non-cash items: (i) depreciation and amortization; (ii) asset impairment charges, (iii) pension adjustments and (iv) net changes to assets and liabilities.

Investing activities

Net cash used for investing activities was $5.0 million in 2021, compared to net cash used for investing activities of $6.5 million in 2020. The following investing activities impacted our cash flow:

Capital expenditures

Capital expenditures in 2021 was $9.1 million compared to $8.0 million in 2020, as we delayed some projects in the prior year in response to COVID-19, and expenditure continued to be delayed in the first half of 2021. We anticipate capital expenditures for 2022 to be around $10 million.

Proceeds from sale of business

In March 2021, the Company sold its U.S. aluminum gas cylinder business for net cash proceeds of $20.2 million. In September 2021, the Company sold its Superform U.K. business for net consideration of $4.0 million, of which $3.0 million was received in 2021 and $1.0 million deferred until September 2022.

In July 2020, the Company sold its 51% investment in Luxfer Uttam India Private Limited for net cash proceeds of $1.5 million. In September 2021, the Company received deferred consideration of $0.3 million for this sale.

In June 2019, the Company sold its Czech recycling business for net cash proceeds of $4.4 million.

Acquisitions, net of cash acquired

In March 2021, the Company completed the acquisition of the SCI business of Worthington Industries, Inc., based in Pomona, California, for $19.3 million cash consideration.

Financing activities

In 2021, net cash used for financing activities was $16.1 million, (2020: $52.5 million). We made net drawdowns on our borrowing facilities of $6.4 million (2020: net repayments of $38.2 million) and dividend payments of $13.6 million (2020: $13.6 million), equating to $0.50 per ordinary share. In 2021, the Company initiated a share buyback programme and has spent $6.4 million repurchasing approximately 300,000 shares.

Loan Notes 2023 and 2026

The Note Purchase Agreement contains customary covenants and events of default, in each case with customary and appropriate grace periods and thresholds. In addition, the Note Purchase Agreement requires us to maintain compliance with a minimum interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Note Purchase Agreement) to Net Finance Charges (as defined in the Note Purchase Agreement). We are required to maintain an interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Note Purchase Agreement) to Adjusted Acquisition EBITDA (as defined in the Note Purchase Agreement). We are required to maintain a leverage ratio of no more than 3.0:1. We have been in compliance with the covenants under the Note Purchase Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2021.

The Loan Notes due 2023 and 2026 and the Note Purchase Agreement are governed by the law of the State of New York.

The Loan Notes due 2023 and 2026 are denominated in U.S. dollars, which creates a natural partial offset between the dollar-denominated net assets and earnings of our U.S. operations and the dollar-denominated debt and related interest expense of the notes. We have included the Note Purchase Agreement and a form of the Loan Notes due 2023 and 2026 as exhibits to this Annual Report and refer you to the exhibits for more information on the Note Purchase Agreement and the Loan Notes due 2023 and 2026.

37

Loan Notes due 2021 and Shelf Facility

The Loan Notes due 2021 were due to mature on September 15, 2021. However, we voluntarily chose to repay the notes early on December 31, 2020, largely using surplus cash generated from operations, plus a small drawing on the Senior Facilities Agreement. In addition to the repayment of the $25 million principal, we incurred an early repayment charge of $0.5 million.

The Note Purchase and Private Shelf Agreement contains the same customary covenants and events of default as for the Note Purchase Agreement. The Note Purchase and Private Shelf Agreement also requires us to maintain compliance with the same interest and leverage ratios as for the Note Purchase Agreement. The Shelf Facility was amended in October 2021, with no material amendments to the agreement.

We have been in compliance with the covenants under the Note Purchase and Private Shelf Agreement throughout all of the quarterly measurement dates from and including September 30, 2014, to the eventual repayment on December 31, 2020.

The Loan Notes due 2021, and Shelf Facility, and the Note Purchase and Private Shelf Agreement are all governed by the law of the State of New York.

Senior Facilities Agreement

A new Senior Facilities Agreement was signed in October 2021, for more information see ITEM 8 Note 11.

Structure.    The current Senior Facilities Agreement provides $100 million of committed debt facilities in the form of a multi-currency (GBP sterling, U.S. dollars or euros) Revolving Credit Facility and an additional $50 million of uncommitted facilities through an accordion clause. The facilities mature in October 2026. As of December 31, 2021, we had drawn down $10.8 million under the Revolving Credit Facility (December 31, 2020: $4.1 million).

Availability.    The facility is used for loans and overdrafts. Amounts unutilized under the Revolving Credit Facility (or, if the case, under the revolving portion of the accordion) are allocated to ancillary facilities available under the Senior Facilities Agreement in connection with overdraft facilities, bilateral loan facilities and letter of credit facilities. As of December 31, 2021, we had drawn down $nil under the ancillary facilities (December 31, 2020: $nil). We may use amounts drawn under the Revolving Credit Facility for our general corporate purposes and certain capital expenditures, as well as for the financing of permitted acquisitions and reorganizations. As of December 31, 2021, $89.2 million (net of $10.8 million drawn down) was available under the Revolving Credit Facility. The last month in which we may draw funds from the Revolving Credit Facility is September 2026.

The Company also had three separate (uncommitted) bonding facilities for bank guarantees: two denominated in GBP sterling totalling £0.6 million (2021: $0.9 million) and one denominated in USD of $1.5 million. Of that denominated in GBP, £0.1 million ($0.2 million) was utilized at December 31, 2021. Of that denominated in USD, $0.9 million was utilized at December 31, 2021.

Interest rates and fees.    Borrowings under the facility bear an interest rate equal to an applicable margin plus either EURIBOR, in the case of amounts drawn in euros, or SONIA (Sterling Overnight Index Average), in the case of amounts drawn in GBP sterling or U.S. dollars.

The tables below sets out the range of ratios and the related margin percentage currently in effect.

LeverageMargin
(% per annum)
Greater than 2.5:12.75
Less than or equal to 2.5:1, but greater than 2.0:12.50
Less than or equal to 2.0:1, but greater than 1.5:12.25
Less than or equal to 1.5:1, but greater than 1.0:12.00
Less than or equal to 1.0:11.75

As of December 31, 2021, we had drawn down $10.8 million under the Revolving Credit Facility (December 31, 2020: $4.1 million). A commitment fee is levied each quarter against any unutilized element of the Revolving Credit Facility, excluding overdraft or ancillary facilities.

In the event of a sale of all or substantially all of our business and / or assets, or if any person or group of persons acting in concert gains direct or indirect control (as defined in the Senior Facilities Agreement) of Luxfer Holdings PLC, we will be required to immediately repay all outstanding amounts under the Revolving Credit Facility (and, if the case, the accordion) and the ancillary facilities under the Senior Facilities Agreement.

38

In addition, the Senior Facilities Agreement requires us to maintain compliance with an interest coverage ratio and a leverage ratio. The interest coverage ratio measures our EBITDA (as defined in the Senior Facilities Agreement) to Net Finance Charges (as defined in the Senior Facilities Agreement). We are required to maintain a minimum interest coverage ratio of 4.0:1. The leverage ratio measures our Total Net Debt (as defined in the Senior Facilities Agreement) to the Relevant Period Adjusted Acquisition EBITDA (as defined in the Senior Facilities Agreement). We are required to maintain a leverage ratio of no more than 3.0:1.

We have been in compliance with the covenants under the Senior Facilities Agreement throughout all of the quarterly measurement dates from and including September 30, 2011, to December 31, 2021.

The Senior Facilities Agreement is governed by English law.

For more information see ITEM 8, Note 11.

Dividends

We paid dividends in 2021 of $13.6 million (2020: $13.6 million), or $0.50 per ordinary share.

Any payment of dividends is also subject to the provisions of the U.K. Companies Act, according to which dividends may only be paid out of profits available for distribution determined by reference to financial statements prepared in accordance with the Companies Act and the International Accounting Standards Board, which differ in some respects from U.S. GAAP. In the event that dividends are paid in the future, holders of the ordinary shares will be entitled to receive payments in U.S. dollars in respect of dividends on the underlying ordinary shares in accordance with the deposit agreement. Furthermore, because we are a holding company, any dividend payments would depend on cash flows from our subsidiaries.

Authorized shares

Our authorized share capital consists of 40.0 million ordinary shares with a par value of £0.50 per share.

Contractual obligations

The following summarizes our significant contractual obligations that impact our liquidity:

Payments Due by Period
In millionsTotalLess than 1 year1 – 3 years3 – 5 yearsAfter 5 years
Contractual cash obligations
Loan Notes due 202325.025.0
Loan Notes due 202625.025.0
Revolving Credit Facility10.810.8
Obligations under operating leases19.63.04.82.98.9
Capital commitments1.51.5
Interest payments16.43.35.42.35.4
Total contractual cash obligations$98.3$7.8$35.2$41.0$14.3

Off-balance sheet measures

At December 31, 2021, we had no off-balance sheet arrangements other than the three bonding facilities as described above.

COMMITMENTS AND CONTINGENCIES

Capital commitments

At December 31, 2021, the Company had capital expenditure commitments of $1.5 million (2020: $1.1 million and 2019: $1.0 million) for the purchase of new plant and equipment.

Committed banking facilities

The Company refinanced in October 2021, see Note 11 for details of the refinance.

At December 31, 2021 the Company had committed banking facilities of $100.0 million with an additional $50.0 million of uncommitted facilities through an accordion provision. Of these committed facilities, $10.8 million was drawn at December 31, 2021.

At December 31, 2020, the Company had committed banking facilities of $150.0 million with an additional $50.0 million of uncommitted facilities through an accordion provision. Of the committed facilities, $4.1 million was drawn at December 31, 2020.

39

Contingencies

During February 2014, a cylinder was sold to a long-term customer and ruptured at one of their gas facilities. As a result of this rupture, three people were noted to have injuries, such as loss of hearing. There was no major damage to assets of the customer. A claim has been launched by the three people who were injured in the incident. We have reviewed our quality control checks from around the time which the cylinder was produced and no instances of failures have been noted. It has also been noted by the investigator that the customer has poor quality and safety checks. In November 2021, during the final hearing, the Court found the representative of Luxfer Gas Cylinders Limited, not guilty and thus the Company was found not liable. The Civil case is still ongoing but as a result, of the above, we do not believe that we are liable for the incident, and therefore, do not currently expect this case to have a material impact on the Company's financial position or results of operations.

In November 2018, an alleged explosion occurred at a third-party waste disposal and treatment site in Boise, Idaho, reportedly causing property damage, personal injury, and one fatality. We had contracted with a service company for removal and disposal of certain waste resulting from the magnesium powder manufacturing operations at the Reade facility in Manchester, New Jersey. We believe this service company, in turn, apparently contracted with the third-party disposal company, at whose facility the explosion occurred, for treatment and disposal of the waste. In November 2020, we were named as a defendant in three lawsuits in relation to the incident – one by the third-party disposal company, one by the estate of the decedent, and one by an injured employee of the third-party disposal company. At present, we have received insufficient information on the cause of the explosion. We do not believe that we are liable for the incident, have asserted such, and, therefore, do not currently expect this matter to have a material impact on the Company’s financial position or results of operations.

NEW ACCOUNTING STANDARDS

See ITEM 8, Note 1 of the notes to the Consolidated Financial Statements, included in this Form 10-K, for information pertaining to recently adopted accounting standards or accounting standards to be adopted in the future.

CRITICAL ACCOUNTING ESTIMATES

We have adopted various accounting policies to prepare the consolidated financial statements in accordance with GAAP. Our significant accounting policies are more fully described in ITEM 8, Note 1 of the Notes to Consolidated Financial Statements. Certain of our accounting policies require the application of significant judgment by management in selecting the appropriate assumptions for calculating financial estimates. By their nature, these judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, terms of existing contracts, our observance of trends in the industry and information available from other outside sources, as appropriate. We consider an accounting estimate to be critical if:

•it requires us to make assumptions about matters that were uncertain at the time we were making the estimate; and

•changes in the estimate or different estimates that we could have selected would have had a material impact on our financial condition or results of operations.

Our critical accounting estimates include the following:

Impairment of goodwill

Goodwill

Goodwill represents the excess of the cost of acquired businesses over the net of the fair value of identifiable tangible net assets and identifiable intangible assets purchased and liabilities assumed.

Goodwill is tested at least annually for impairment and is tested for impairment more frequently if events or changes in circumstances indicate that the asset might be impaired. Goodwill is tested for impairment by either performing a qualitative evaluation or a quantitative test. The qualitative evaluation is an assessment of factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill. We may elect not to perform the qualitative assessment for some or all reporting units and perform a quantitative impairment test. In 2021, management carried out its qualitative review, which showed no indicators of impairment. As a result, the Company concluded its review and was not required to perform a quantitative review.

We completed our qualitative goodwill impairment evaluation as of the last day of the third quarter of 2021, with each of our reporting units' fair value being substantially in excess of its carrying value.

40

Identifiable intangible assets

Our primary identifiable intangible assets include: (i) customer relationships and technology; and (ii) traded related assets. All our identifiable intangible assets have finite lives and are amortized over that period. Identifiable intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. No such events occurred during the year ended December 31, 2021.

Pension and other post-retirement plans

We sponsor U.S. and non-U.S. defined-benefit pension and other post-retirement plans. The amounts recognized in our consolidated financial statements related to our defined-benefit pension and other post-retirement plans are determined from actuarial valuations. Inherent in these valuations are assumptions, including: (i) discount rates; (ii) inflation rates; (iii) pension increases; and (iv) life expectancy. These assumptions are updated annually and are disclosed in ITEM 8, Note 14 to the Notes to Consolidated Financial Statements. Differences in actual experience or changes in assumptions may affect our pension and other post-retirement obligations and future expense.

We recognize changes in the fair value of plan assets and net actuarial gains or losses for pension and other post-retirement benefits annually in the fourth quarter each year ("mark-to-market adjustment") and, if applicable, in any quarter in which an interim remeasurement is triggered. Net actuarial gains and losses occur when the actual experience differs from any of the various assumptions used to value our pension and other post-retirement plans or when assumptions change as they may each year. The primary factors contributing to actuarial gains and losses each year are (i) changes in the discount rate used to value pension and other post-retirement benefit obligations as of the measurement date and (ii) differences between the expected and the actual return on plan assets. This accounting method also results in the potential for volatile and difficult to forecast mark-to-market adjustments. The remaining components of pension expense, including service and interest costs and the expected return on plan assets, are recorded on a quarterly basis as ongoing pension expense.

Discount rate

The discount rate used represents the annualized yield based on a cash flow matched methodology with reference to an AA corporate bond spot curve and having regard to the duration of the Plan’s liabilities. This yield produced a weighted-average discount rate for our U.K. plans of 1.90% in 2021, 1.40% in 2020 and 2.10% in 2019. The discount rate on our U.S. plans was 2.70% in 2021, 2.30% in 2020 and 3.10% in 2019. There are no known or anticipated changes in our discount rate assumption that will impact our pension expense in 2022.

To indicate the sensitivity of results to this assumption, a 0.1% per annum increase in the discount rate for our U.K. plans would reduce the value of the liabilities and therefore increase the pension surplus by approximately $5.4 million and increase the projected 2022 income statement credit by approximately $0.1 million. Similarly, a 0.1% per annum increase in the discount rate for our U.S. plans would reduce the value of the liabilities; and therefore the deficit, by approximately $1.0 million and decrease the projected 2022 income statement credit by approximately $0.1 million.

Inflation rate

In September 2019, the UK Statistics Authority announced plans to reform the RPI inflation index. On November 25, 2020, the government and UK Statistics Authority confirmed these plans to reform the RPI index to bring it into line with the CPIH index from 2030, with no compensation for the holders of index-linked gilts. Inflation measured by the CPIH is consistently significantly lower than that measured by RPI, and therefore, these plans imply a significant expected reduction in RPI inflation from 2030 onwards. As a result we have taken a stepped approach and used different inflation rates pre and post 2030.

To indicate the sensitivity of results to the CPI assumption, a 0.1% per annum decrease in all CPI-linked assumptions, (including pension increases) would reduce the value of the liabilities and therefore increase the pension surplus at December 31, 2021 by approximately $5.4 million and increase the projected 2022 income statement credit by approximately $0.3 million.

41

Pension increases

The pension increase assumptions have been set with reference to the corresponding CPI inflation assumption and take account of the caps and floors applicable to the various components of pension indexation.

Life expectancy

The life expectancies of male and female members aged 65 on 31 December 2021 are assumed to be 21.1 and 22.9 years, respectively, with the life expectancies of male and female members aged 65 on 31 December 2041 assumed to be 22.4 and 24.4 years, respectively.

To indicate the sensitivity of results to the life expectancy assumption, a one year increase in assumed life expectancy could increase the value of the liabilities and therefore decrease the pension surplus at December 31, 2021 by approximately $14.8 million and reduce the projected 2022 income statement credit by approximately $0.8 million.

Expected rate of return

Our expected rate of return on plan assets for our U.K. plans was 3.30% in 2021, 3.00% in 2020 and 4.10% in 2019. The expected rate of return on our U.S. plans was 2.50% in 2021, 5.00% in 2020 and 6.20% in 2019. The expected rate of return is designed to be a long-term assumption that may be subject to considerable year-to-year variance from actual returns. In developing the expected long-term rate of return, we considered our historical returns, with consideration given to forecast economic conditions, our asset allocations, input from external consultants and broader longer-term market indices.

See ITEM 8, Note 14 of the Notes to Consolidated Financial Statements for further information regarding pension and other post-retirement plans.

Loss contingencies

Accruals are recorded for various contingencies, including legal proceedings, self-insurance and other claims that arise in the normal course of business. The accruals are based on judgment, the probability of losses and, where applicable, the consideration of opinions of internal and/or external legal counsel and actuarial determined estimates. Additionally, we record receivables from third party insurers when recovery has been determined to be probable.

Our critical judgment revolves around the recognition of litigation and environmental liabilities in relation to the closure of our French site. We have recognized a loss contingency of $11.2 million, for which we have engaged with external experts to assist with the valuation of these liabilities.

42